Holiday Notification: Cayman Chemical will be closed Monday, September 6, 2010, in observance of the Labor Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, September 7, 2010. Thank you for your patience.
Research Area · Neuroscience
· See all 100+ product categories
| Item Number | Product | Sizes & Pricing | CAS | Purity | Image | Exclusive | Introduction Date | Mojo | Plain Text Name | Synonyms | Keywords |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 33400 |
(±)10- |
90780-50-0 | >98% |
|
8.433816758747 | -10-hdohe | 10-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)10-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 10008598 |
(±)11(12)- |
- | >98% |
|
✓ | 2007-01-16 | 31.951303867403 | -11-12-eet-ethanolamide | (±)11(12)-EpETrE Ethanolamide | AEA endocannabinoids Arachidonoyl ethanolamides CYP450 cytochromes metabolism neurochemistry anxiety depression 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide anandamides lipids neurotransmitters cannabinergic cannabinoids CBs FAAH inhibitor fatty acids hydrolases | |
| 10010101 |
11- |
6186-98-7 | >98% |
|
2007-08-06 | 9.973812154696 | 11-cis-vaccenyl-acetate | d. melanogaster pheromones olfactory receptors mating male female specific insects flys fruit flies Or67d odorant hydrocarbon | |||
| 33450 |
(±)11- |
87018-59-5 | >98% |
|
7.419307090239 | -11-hdohe | 11-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)11-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 10009473 |
1,2- |
63-89-8 | >98% |
|
2007-01-19 | 8.651617995264 | 1-2-dipalmitoyl-sn-glycero-3-pc | L-dipalmitoyl Lecithin; L-DPPC; 1,2-dipalmitoyl-sn-glycero-3-Phosphatidylcholine | antigens phosphatidylcholines zwitterionic phosphoglycerides proteoliposomes liposomal enzymes g-glutamyl gamma-glutamyl .gamma.-glutamyl transpeptidase erythrocytes immunotherapy immunotherapies GSLs glycosphingolipids phospholipids polyenylphosphatidylcholine | ||
| 90377 |
13- |
112-84-5 | >98% |
|
0.197237569061 | 13-docosenamide | Erucamide; Armoslip E | CSF sleep fatty acids neurochemistry neuroscience | |||
| 33500 |
(±)13- |
90780-53-3 | >98% |
|
11.103225138121 | -13-hdohe | 13-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)13-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 10008599 |
(±)14(15)- |
- | >95% |
|
✓ | 2006-08-07 | 25.900764272560 | -14-15-eet-ethanolamide | (±)14(15)-EpETrE Ethanolamide; (±)14(15)-Epoxy Eicosatrienoyl Ethanolamide | CYP450 cytochrome P450 metabolites AEA arachidonoyl ethanolamides anandamide lipids neurotransmitter cannibinergic cannabinoid CB1 CB2 receptors enzymatic metabolism FAAH fatty acid amide hydrolases endocannabinoid neurochemistry anxiety depression neuroscience 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide | |
| 33550 |
(±)14- |
87042-40-8 | >98% |
|
14.898119244936 | -14-hdohe | 14-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)14-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 10169 |
15(S)- |
161744-53-2 | >98% |
|
29.785220994475 | 15-s-hete-ethanolamide | 15(S)-HAEA | neurotransmitters ethanolamides fatty acids endocannabinoids CB receptors amide hydrolases FAAH neurochemistry neuroscience ethanolamines 15HETE | |||
| 10174 |
16(17)- |
- | >90% |
|
2004-01-14 | 34.599917127071 | 16-17-epdpe | 16,17-epoxy Docosapentaenoic Acid | epoxides epoxygenases cytochrome P450 (±)16,17-EpDPEs (+/-)16,17-EpDPEs fatty acids (+/-)16(17)EpDPEs 16(17)EETs eicosatrienoic neurochemistry | ||
| 33600 |
(±)16- |
90780-51-1 | >98% |
|
7.419307090239 | -16-hdohe | 16-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)16-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 33650 |
(±)17- |
90780-52-2 | >98% |
|
12.725023374415 | -17-hdohe | 17-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)17-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 10005099 |
17(R)- |
155976-53-7 | >98% |
|
✓ | 2005-01-05 | 72.729723756906 | 17-r-hdohe | 17(R)-hydroxy Docosahexaenoic Acid | resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry | |
| 10009799 |
17(S)- |
- | >98% |
|
2007-03-12 | 69.213922651933 | 17-s-hdohe | 17(S)-hydroxy Docosahexaenoic Acid | resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry | ||
| 10175 |
19(20)- |
- | ≥98% |
|
2004-01-14 | 49.733204419889 | 19-20-epdpe | 19,20-epoxy Docosapentaenoic Acid | metabolites epoxides epoxygenases cytochrome P450 (±)19,20-EpDPEs (+/-)19,20-EpDPEs fatty acids (+/-)19(20)EpDPEs 19(20)EETs eicosatetraenoic 19,20-EETs neurochemistry | ||
| 62150 |
1- |
35474-99-8 | >98% |
|
✓ | 13.722985635359 | 1-arachidonoyl-glycerol | 1-AG | cannabinoids glycerol anandamides fatty acids neurochemistry neuroscience | ||
| 362152 |
1- |
- | ≥99% deuterated product |
|
48.221754143646 | 1-arachidonoyl-glycerol-d5 | 1-AG-d5 | deuterium isotopes GC/MS endocannabinoids anandamides 1AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 1-AG-d5 internal fatty acids | |||
| 33750 |
(±)20- |
90906-41-5 | >98% |
|
12.104127532228 | -20-hdohe | 20-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)20-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 10009501 |
20- |
- | >95% |
|
2008-04-23 | 8.482357274401 | 20-hydroxy-n-arachidonoyl-taurine | metabolism metabolites CYP450 20-HETE taurines vasoconstrictors TRPV1 TRPV4 FAAH | |||
| 64970 |
2- |
524-95-8 | >98% |
|
18.680902394106 | 2-apb | receptors inositol-1,4,5-triphosphates calcium signalling ins(1,4,5)IP3 blocked inositols antagonists Ca2+ neurochemistry neuroscience | ||||
| 62160 |
2- |
53847-30-6 | >95% (as a 9:1 mixture of the 2-AG and 1-AG) |
|
93.837913180742 | 2-arachidonoyl-glycerol | 2-AG | endocannabinoids anandamides 2AG fatty acids CB1 neuroscience neurochemistry endocrinology | |||
| 362162 |
2- |
- | ≥99% deuterated product |
|
70.564378453039 | 2-arachidonoyl-glycerol-d5 | 2-AG-d5 | deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 2-AG-d5 internal fatty acids lipids neurochemistry neuroscience endocrinology | |||
| 362160 |
2- |
- | ≥99% deuterated product |
|
96.031988950276 | 2-arachidonoyl-glycerol-d8 | 2-AG-d8 | deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d8 GC-MS mass spectrometry LC/MS LC-MS deuterated standards internal neurochemistry neuroscience endocrinology | |||
| 62165 |
2- |
222723-55-9 | >98% |
|
45.423701657459 | 2-arachidonyl-glycerol-ether | Noladin; 2-AG ether | endocannabinoids 2AG anandamides CB1 receptor selective selectivity agonists stable 2-AG-ether analogs fatty acids neurochemistry neuroscience lipids | |||
| 62260 |
2- |
3443-82-1 | >98% |
|
✓ | 22.293922651933 | 2-linoleoyl-glycerol | 2-LG | CB1 glycerols 2LG cannabinoids 2-Linoleoyl-Glycerol reuptake endocannabinoids receptors congeners fatty acids neurochemistry neuroscience lipids | ||
| 90055 |
(±)- |
166100-39-6 | >95% |
|
24.515589318600 | -2-methyl-arachidonoyl-2-fluoroethylamide | O-689; 2-Methyl-2'-fluoro Anandamide; 2-methyl-2'-fluoro AEA | anandamides ethanolamides AEA cannabinoids receptors CB1 binding affinity faah fatty acid hydrolases .DELTA.9-THC .DELTA.9THC DELTA9-THC DELTA9THC D9-THC D9THC tetrahydrocannabidiol selective analogs neurochemistry neuroscience fluoromethanandamide | |||
| 10007980 |
3,4- |
- | >95% |
|
2006-08-09 | 9.599723756906 | 3-4-daa | Trp tryptophan Multiple Sclerosis MS T helper-1 TH1 cytokines EAE encephalomyelitis inflammation immunity autoimmune autoimmunity cells cytokines | |||
| 90314 |
4(5)- |
121818-29-9 | >98% |
|
21.682928176795 | 4-5-epdpe-methyl-ester | 4,5-epoxy Docosapentaenoic Acid methyl ester | cytochrome P450 metabolites epoxide epoxygenase neurochemistry | |||
| 33200 |
(±)4- |
90906-40-4 | >98% |
|
13.391777564256 | -4-hdohe | 4-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)4-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 13265 |
4- |
1011268-23-7 | ≥98% |
|
✓ | 2010-06-16 | 0E-12 | 4-hydroxy-nonenal-alkyne | Click Tag™ 4-HNE alkyne | lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT | |
| 10008596 |
(±)5(6)- |
- | >95% |
|
✓ | 2006-10-20 | 11.558705603788 | -5-6-eet-ethanolamide | (±)5(6)-EpETrE Ethanolamide | epoxides epoxygenases 5,6-EETs cytochrome P450 (+/-)5(6)-EpETrEs (+/-)5,6-EpETrEs fatty acids esters ethanolamides metabolites AEA anandamides arachidonoyl neurotransmitters cannabinergic endocannabinoids CB1 CB2 receptors central peripheral FAAH hydrolases metabolism lipoxygenases inhibition (±)5(6)-Epoxy eicosatrienoyl 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide | |
| 10009315 |
6- |
329-89-5 | ≥98% |
|
2008-11-21 | 0.472375690608 | 6-aminonicotinamide | 6-AN; NSC 21206; SR 4388 | inhibitors inhibits inhibition 6-phosphoguconate dehydrogenase cancers ATPs oxidative injury neurodegeneration cardiovascular | ||
| 10010670 |
7- |
- | ≥99% deuterated product |
|
2009-04-17 | 0E-12 | 7-aminoclonazepam-d4 | seizures myotonic atonic epilepsy receptors acids deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry | |||
| 33300 |
(±)7- |
90780-55-5 | >98% |
|
12.490425874770 | -7-hdohe | 7-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)7-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 81340 |
7- |
2942-42-9 | >98% |
|
7.973508287293 | 7-nitroindazole | nitric oxide synthases inhibitors nNOS eNOS iNOS inhibits anti-nociceptive antinociceptive neurochemistry | ||||
| 10006878 |
8,12- |
- | >99% deuterated product |
|
2005-09-01 | 18.056574585636 | 8-12-iso-ipf2-vi-d11 | 8,12-epi-iPF2α-VI-d11 | GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry analogs internal standards isoprostanes prostaglandins free-radical lipid peroxidation stero- regioisomers arachidonic acids 8-isoprostane 8-epi-PGF2.alpha. iPF2.alpha.-III oxidative stress Type VI class internal lactones facilitates extraction and purification neurochemistry neuroscience | ||
| 10008597 |
(±)8(9)- |
- | >98% |
|
2007-07-05 | 15.586008287292 | -8-9-eet-ethanolamide | (±)8(9)-EpETrE Ethanolamide | AEA endocannabinoids arachidonoyl ethanolamide CYP450 cytochrome P450 metabolism ethanolamides hypertension | ||
| 10010109 |
8- |
- | ≥98% |
|
2008-10-23 | 681.100662983425 | 8-dy547-cgmp | CNGA2 channels activators fluorescences cyclic nucleotides | |||
| 33350 |
(±)8- |
90780-54-4 | >98% |
|
7.800522559853 | -8-hdohe | 8-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)8-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 316350 |
8- |
211105-40-7 | ≥99% deuterated product |
|
89.057449355433 | 8-iso-prostaglandin-f2-d4 | 15-F2t-Isoprostane-d4; iPF2α-III-d4; 8-epi PGF2α-d4; 8-Isoprostane-d4 | GC/MS deuterium isotopes 8-isoprostanes 8-epi-PGF2.alpha.-d4 8-epi-PGF2alpha-d4 8-iso-PGF2.alpha.-d4 8-iso-PGF2alpha-d4 internal standards prostaglandins mass spectrometry LC/MS GC-MS LC-MS deuterated 8-iso-PGF2a-d4 8-epi-PGF2a-d4 ipf2a neurochemistry 316351 | |||
| 516351 |
8- |
- |
|
962.085051302288 | 8-isoprostane-eia-kit | iPF2α-III EIA Kit; 8-epi Prostaglandin F2α EIA Kit; 8-iso Prostaglandin F2α EIA Kit; 8-Isoprostane ELISA Kit | oxidative injury stress reactive oxygen species 8-isoprostanes 8-epi-PGF2.alpha. 8-epi-PGF2alpha 8-iso-PGF2.alpha. 8-iso-PGF2alpha prostaglandins free radicals ROS peroxidation lipids measures kits eias enzyme immunoassays ELISAs assays | ||||
| 516360 |
8- |
- |
|
2009-10-26 | 190.972742531549 | 8-isoprostane-express-eia-kit | 8-epi Prostaglandin F2α Express EIA Kit; iPF2α-III Express EIA Kit; 8-Isoprostane Express ELISA Kit; 8-iso Prostaglandin F2α Express EIA Kit | oxidative injury stress reactive oxygen species 8-isoprostanes 8-epi-PGF2.alpha. 8-epi-PGF2alpha 8-iso-PGF2.alpha. 8-iso-PGF2alpha prostaglandins free radicals ROS peroxidation lipids measures kits eias enzyme immunoassays ELISAs | |||
| 516361 |
8- |
- |
|
2009-10-26 | 158.175725380169 | 8-isoprostane-express-eia-kit-solid-plate | oxidative injury stress reactive oxygen species 8-isoprostanes 8-epi-PGF2.alpha. 8-epi-PGF2alpha 8-iso-PGF2.alpha. 8-iso-PGF2alpha prostaglandins free radicals ROS peroxidation lipids measures kits eias enzyme immunoassays ELISAs | ||||
| 90375 |
9- |
301-02-0 | >98% |
|
5.843005524862 | 9-octadecenamide | Oleamide; cis-9-octadecenamide | CSF sleep 9Z-octadecenamide fatty acids neurochemistry neuroscience | |||
| 10012588 |
A- |
944261-79-4 | ≥98% |
|
2009-02-14 | 0.132596685083 | a-803467 | Nav1.8 sodium channels neuropathic pain inflammatory blockers inhibitors inhibits inhibition TTX-resistance TTX-R | |||
| 10092 | Adenosine Receptor A2A Blocking Peptide | - | 2009-04-03 | 199.064604051565 | adenosine-receptor-a2a-blocking-peptide | A2AR | blocking peptides Western blots immunoblotting ARA2A | ||||
| 10005254 | AFMK | 52450-38-1 | >98% |
|
2004-10-28 | 2.319240932020 | afmk | melatonin metabolites metabolism radicals scavengers neurotransmitters eukaryotes circadean rhythms antioxidants plasma synthesis endocrinology neurochemistry | |||
| 13203 | Agomelatine | 138112-76-2 | ≥98% |
|
2009-11-06 | 3.478260869565 | agomelatine | Valdoxan® | melatonin circadian rhythm MT1 MT2 serotonin 5-HT noradrenaline dopamine antidepressant anti-depressant S20098 S-20098 S 20098 | ||
| 10011546 | AL 34662 | 210580-75-9 | ≥98% |
|
2008-11-12 | 254.242209944751 | al-34662 | AL 34497 | serotonins 5-HTs 5HT 5-hydroxy trptamine IOPs intraocular pressure glaucoma ophthalmology lower 5-hydroxytrptamine | ||
| 10005223 | AM1172 | 251908-92-6 | >98% |
|
2004-09-01 | 9.959313338595 | am1172 | cannabinoids neurotransmitters inhibitors AEA lipids CB1 CB2 receptors anandamide hydrolysis fatty acids inhibits arachidonoyl ethanolamides reuptake FAAH-resistant amide hydrolases neuroscience neurochemistry | |||
| 10010118 | AM1241 | 444912-48-5 | >97% |
|
2007-08-29 | 33.313569060773 | am1241 | CB1 CB2 cannabinoids receptors agonists antagonists antinociception AM630 AM251 AM-1241 AM 1241 | |||
| 71670 | AM251 | 183232-66-8 | >98% |
|
40.934475138121 | am251 | cannabinoids receptors antagonists CB1 analogs selective SR-141716-A AM-251 SR141716A neuroscience neurochemistry endocrinology | ||||
| 90060 | AM404 | 183718-77-6 | >98% |
|
10.723016574586 | am404 | N-(4-hydroxyphenyl)-Arachidonoyl Amide; 4-HPA | cannabinoids neurotransmitter inhibitors AEA lipids CB1 CB2 receptors anandamide hydrolysis fatty acids neuroscience neurochemistry | |||
| 10006974 | AM630 | 164178-33-0 | ≥98% |
|
2009-02-09 | 20.384806629834 | am630 | Iodopravadoline | neurochemistry neuroscience cannabinoids CB1 CB2 antagonist inverse agonist antinociception pain receptors | ||
| 10005098 | AMC Arachidonoyl Amide | - | >98% |
|
2004-08-31 | 12.386994475138 | amc-arachidonoyl-amide | 7-amino-4-methyl Coumarin-Arachidonamide; AMC-AA | fatty acid amides hydrolases FAAH anandamides fluorescence coumarin | ||
| 13523 |
Apelin- |
217082-58-1 | ≥95% |
|
2010-06-29 | 0E-12 | apelin-13 | ligands APJ receptors central nervous system cardiovascular functions fluid homeostasis neurosciences hypertension diabetes metabolic syndrome insulin HIV aids | |||
| 10007904 |
Arachidonoyl- |
- | >98% |
|
✓ | 2006-01-24 | 32.750925414364 | arachidonoyl-1-thio-glycerol | 1-S-Arachidonoyl-1-mercapto-2,3-propanediol | cannabinoids monoacylglycerols monoglycerol monoglyceride anandamides fatty acids neurochemistry neuroscience chromogenic substrates lipases 2-arachidonoyls 2-AG agonists central CB1 nervous system CNS rat brains MGL hydrolyzes arachidonic acids thioesters analogs thiols DTNB Ellman's reagents yellow | |
| 91054 |
Arachidonoyl 2'- |
220556-69-4 | >96% |
|
36.301187845304 | arachidonoyl-2-chloroethylamide | 2'-chloro-AEA; ACEA | agonists selective CB1 receptors AEA arachidonoyl ethanolamides cannabinoids selectivity hypothermia FAAH fatty acid amide hydrolases neurochemistry neuroscience thc tetrahydrocannabinoids ethanolamines | |||
| 90054 |
Arachidonoyl- |
166100-37-4 | >98% |
|
7.673518464670 | arachidonoyl-2-fluoroethylamide | 2'-fluoro Anandamide; 2'-fluoro AEA | anandamides cannabinoids neurotransmitters ligands AEA lipids CB1 CB2 receptors neurochemistry neuroscience | |||
| 10007295 | Arachidonoyl amide Exclusive | 85146-53-8 | >98% |
|
✓ | 2006-01-18 | 8.904830307813 | arachidonoyl-amide | Arachidonamide; Arachidonic Acid amide | anandamides arachidonoyl ethanolamides AEA endogenous endocannabinoids CB1 CB2 receptors cellular uptake hydrolysis bonds enzymes fatty acids hydrolases FAAH N,N-dimethyl analogs human inhibits inhibition rat glial gap junction cell-cells communications neurochemistry hydroxyethyl moiety transporter astrocytoma neuroscience | |
| 91053 | Arachidonoyl Cyclopropylamide | 229021-64-1 | >98% |
|
22.307213891081 | arachidonoyl-cyclopropylamide | ACPA | cannabinoids receptors CB1 agonists AEA FAAH fatty acid hydrolases substrates selective analogs anandamide arachiodonyl ethanolamides neurochemistry neuroscience thc tetrahydrocannabinoids ethanolamines | |||
| 90050 | Arachidonoyl Ethanolamide | 94421-68-8 | ≥98% |
|
51.927399368587 | arachidonoyl-ethanolamide | Anandamide; AEA | cannabinoids neurotransmitter ligands lipids CB1 CB2 receptors AEA fatty acids neuroscience neurochemistry ethanolamines ethanolamides endocrinology | |||
| 10011178 |
Arachidonoyl Ethanolamide- |
- | ≥99% deuterated product |
|
2008-03-04 | 74.715911602210 | arachidonoyl-ethanolamide-d4 | AEA-d4; Anandamide-d4 | deuterium GC/MS internal isotopes standards ethanolamides LC/MS mass spectrometry cannabinoids fatty acids deuterated neurochemistry neuroscience ethanolamines | ||
| 390050 |
Arachidonoyl Ethanolamide- |
- | ≥99% deuterated product |
|
51.595607734806 | arachidonoyl-ethanolamide-d8 | Anandamide-d8; AEA-d8 | deuterium GC/MS internal isotopes standards ethanolamides GC-MS LC/MS LC-MS mass spectrometry cannabinoids deuterated fatty acids neurochemistry neuroscience ethanolamines endocrinology | |||
| 10007270 | Arachidonoyl Ethanolamide Lipid Maps MS Standard | 94421-68-8 | ≥98% |
|
7.503635784105 | arachidonoyl-ethanolamide-lipid-maps-ms-standard | AEA; Anandamide | cannabinoids neurotransmitter ligands lipids CB1 CB2 receptors AEA fatty acids neuroscience neurochemistry ethanolamines ethanolamides endocrinology MS mass spectrometry standards | |||
| 10180 | Arachidonoyl Ethanolamide Phosphate | 183323-26-4 | >98% |
|
2004-08-19 | 25.501298342540 | arachidonoyl-ethanolamide-phosphate | AEA-P; Anandamide Phosphate | endocannabinoids neurotransmitters ligands lipids CB1 CB2 receptors fatty acids phosphates anandamides LPA lysophosphatidic ethanolamines ethanolamides | ||
| 90051 | Arachidonoyl Glycine | 179113-91-8 | >98% |
|
19.357370165746 | arachidonoyl-glycine | NAGly | cannabinoids ligands lipids CB1 receptors AEA anandamides ethanolamides fatty acids neurochemistry neuroscience | |||
| 10007531 |
Arachidonoyl Glycine- |
- | ≥99% deuterated product |
|
2005-09-13 | 21.321215469612 | arachidonoyl-glycine-d8 | N-Arachidonyl Glycine-d8; NAGly-d8 | deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated cannabinoids ligands lipids CB1 receptors AEA anandamides ethanolamides fatty acids neurochemistry neuroscience | ||
| 90059 |
Arachidonoyl m- |
- | >98% |
|
✓ | 25.001143646409 | arachidonoyl-m-nitroaniline | AmNA | FAAH substrates anandamides hydrolases colorimetric cannabinoids fatty acids meta-nitroaniline aea nitroanilines nitroanalines neurochemistry neuroscience | ||
| 10007294 |
Arachidonoyl- |
156910-29-1 | >98% |
|
2006-01-18 | 8.601752170481 | arachidonoyl-n-methyl-amide | acids anandamides arachidonoyl ethanolamides AEA endogenous endocannabinoids CB1 CB2 receptors cellular uptake hydrolysis bonds enzymes fatty acids hydrolases FAAH N,N-dimethyl analogs human inhibits inhibition rat glial gap junction cell-cells comunications neurochemistry neuroscience | |||
| 10007293 |
Arachidonoyl- |
45280-17-9 | >98% |
|
2006-01-11 | 9.965603788476 | arachidonoyl-n-n-dimethyl-amide | Arachidonic Acid-N,N-dimethyl amide | anandamides arachidonoyl ethanolamides AEA endogenous endocannabinoids CB1 CB2 receptors cellular uptake hydrolysis bonds enzymes fatty acids hydrolases FAAH N,N-dimethyl analogs human inhibits inhibition rat glial gap junction cell-cells comunications neurochemistry neuroscience | ||
| 10168 |
Arachidonoyl p- |
119520-58-0 | >98% |
|
2004-12-01 | 25.287612470402 | arachidonoyl-p-nitroaniline | ApNA | FAAH substrates anandamides hydrolases colorimetric cannabinoids fatty acids para-nitroaniline aea nitroanilines arachidonoyl ethanolamides neurochemistry neuroscience | ||
| 62170 | Arachidonoyl Serinol | 183718-70-9 | >98% |
|
63.543314917127 | arachidonoyl-serinol | endocannabinoids anandamides 2AG CB1 receptors neurochemistry neuroscience | ||||
| 70665 | Arachidonoyl Serotonin | 187947-37-1 | >98% |
|
14.149300184161 | arachidonoyl-serotonin | AA-5HT | inhibitors fatty acids amides hydrolase FAAH inactivation cannabinoids AA-5HT neurochemistry neuroscience | |||
| 62120 | Arachidonyl Trifluoromethyl Ketone | 149301-79-1 | >98% |
|
48.946595303867 | arachidonyl-trifluoromethyl-ketone | ATK; AATFMK | ATK AACOCF3 inhibitors PLA2 analogs fatty acids lipoxygenases inhibition inhibits LOs neurochemistry neuroscience | |||
| 10005765 | Arachidoyl Ethanolamide Exclusive | 94421-69-9 | >98% |
|
✓ | 2005-06-22 | 16.984751381215 | arachidoyl-ethanolamide | N-Arachidoylethanolamine | arachidoyls ethanolamides N-acyls saturated anandamides analogs enocannabinoids CB1 CB2 memory weight loss appetite neurodegeneration tumors arachidoylethanolamide surveillance analgesia inflammations fatty hydrolytic enzymes FAAH acid amides hydrolases AEA neurochemistry neuroscience ethanolamines | |
| 9000325 | Arachidoyl glycine | 617703-96-5 | ≥98% |
|
2008-12-02 | 1.049668508286 | arachidoyl-glycine | arachidic acid glycine fatty acids PUFAs polyunsaturated fatty acids | |||
| 13662 | Arecoline (hydrobromide) New | 300-08-3 | ≥95% |
|
2010-08-19 | 1.559723756906 | arecoline-hydrobromide | 63-75-2 alkaloids betel nuts Areca agonists muscarinic acetylcholine receptors M1 M2 M3smooth muscles contractions learning memory dementia Alzheimer’s diseases | |||
| 90052 | Arvanil | 128007-31-8 | >98% |
|
16.979627071823 | arvanil | N-Vanillylarachidonamide | capsaicin capsicum vanilloids receptors agonists cannabinoids analgesia anandamides analgesic vanillylamines amides neurochemistry neuroscience | |||
| 13644 | Aspalatone Exclusive | 147249-33-0 | ≥98% |
|
✓ | 2010-02-19 | 64.697395547684 | aspalatone | Acetylsalicylic Acid Matol ester | antioxidants platelet aggregation thrombosis epilepsy kainic acid thromboembolism anti-platelets antiplateles | |
| 13160 |
AT- |
162640-98-4 | ≥95% |
|
✓ | 2010-06-22 | 7.811430325353 | at-56 | Prostaglandins D synthases L-PGDS PGD2 lipocalin-type inflammation inhibition inhibitors inhibits PGs eosinophils LPGDs bronchoalveolar lavage fluid | ||
| 10009410 |
ATF2 (Phospho- |
- | 2006-11-28 | 0.814917127071 | atf2-phospho-ser490-498-polyclonal-antibody | Activating Transcription Factor 2 | wb western blotting blots ihc immunohistochemistry antibodies activating transcriptional factors CRE-BP1 AP-1 DNA response elements ATF/CREB leucine zipper proteins regulating regulation genes cytokines cells cycles controls apoptosis death cellular stress inflammatory UV irradiation activity phosphorylation serines brains substrates neuronal neurons growth differentiation human depression phospho-specific immunoblotting | ||||
| 10009021 |
AVE- |
358970-97-5 | >98% |
|
✓ | 2008-04-03 | 9.255248618785 | ave-1625 | cannabinoids CB1 receptors schizophrenia parkinsons disease alzheimers disease metabolism obesity SR-141716 lipolysis glycogenolysis antagonist endocrinology neurochemistry | ||
| 10227 | BACE (human recombinant) | - | ≥95% | 2009-03-09 | 50.357384898711 | bace-human-recombinant | Memapsin-2; β-Secretase; ASP-1; BACE-1; Membrane-bound Aspartic Protease | proteins amyloids peptides C-terminus terminal alzheimers neurochemistry | |||
| 600070 | BACE Inhibitor Screening Assay Kit | - |
|
2009-03-26 | 49.041141804788 | bace-inhibitor-screening-assay-kit | β-Secretase Inhibitor Screening Assay Kit | inhibitors inhibition inhibits assays kits β-sites .beta.-sites b-sites APP cleaving enzymes β-amyloids .beta.-amyloids b-amyloids peptides Ab A.beta. brain neurodegeneration Alzheimer's Diseases AD proteolytic cleavages precursors β-secretases b-secretases γ-secretases .gamma.-secretases g-secretases membranes aspartic C-terminal C-terminus fragments proteolysis therapeutics therapy cascade pathogenesis mice mouse murine transgenics cholinergic dysfunctions HIV humans fluorescents fluorescences fluorometer assays | |||
| 10011135 |
BAY- |
439083-90-6 | ≥98% |
|
2009-03-13 | 50.968139963168 | bay-60-7550 | inhibitors inhibits inhibition cyclic nucleotides cGMP cAMP cells signalling signaling PDE2 memory memories phosphodiesterase | |||
| 10005836 |
bis(7)- |
224445-12-9 | >98% |
|
2005-04-15 | 2.029171270718 | bis-7-tacrine | 1,7-N-heptylene-bis-9,9'-amino-1,2,3,4-tetrahydro-acridine | dimeric congeners amino acridines inhibits inhibitors inhibition acetylcholinesterases Alzheimer's disease hydrogen peroxides apoptosis pheochromocytoma cells neurochemistry neuroscience | ||
| 10488 | Bupropion (hydrochloride) New | 31677-93-7 | ≥98% |
|
2010-08-16 | 0E-12 | bupropion-hydrochloride | NSC 315851 | 34841-36-6 Zyban Wellbatrin inhibitors inhibits inhibition reuptake dopamine norepinephrine Voxra Aplenzin Amfebutamone antagonists neuronal acetylcholine nicotinic receptors nAChR antidepressant depression neurosciences | ||
| 70090 | BW 723C86 | 160521-72-2 | >98% |
|
28.647624309392 | bw-723c86 | bw-723c86 bw723-c86 5-ht2b agonist anxiolytic serotonin 5-hydroxy-tryptamine 5-OH-tryptamine bw723c86 receptors selective endocrinology neurochemistry neuroscience | ||||
| 10011437 | CaMKII Monoclonal Antibody (Clone 6G9) | - | 2008-05-20 | 5.419889502762 | camkii-monoclonal-antibody-clone-6g9 | Calcium/Calmodulin-dependent Protein Kinase II | calcium calmodulin signalling signaling WB IHC IP EIA IF western blots immunohistochemistry immunoprecipitation immunofluorescence antibodies antiserum kinases neurochemistry enzyme immunoassays immunoblotting PPI PKA blotting | ||||
| 10011438 |
CaMKII (phospho- |
- | 2008-05-20 | 5.419889502762 | camkii-phospho-thr286-thr287-monoclonal-antibody-clone-22b1 | Calcium/Calmodulin-dependent Protein Kinase II | calcium calmodulin signalling signaling WB IHC IP EIA IF western blots immunohistochemistry immunoprecipitation immunofluorescence antibodies antiserum kinases neurochemistry immunoblotting enzyme immunoassays PPI PKa blotting | ||||
| 90080 | Cannabidiol (DEA Schedule I Regulated Compound) | 13956-29-1 | >99% |
|
25.562288871349 | cannabidiol-dea-schedule-i-regulated-compound | delta9-THC .DELTA.9-THC delta9THC .DELTA.9THC marijuana neuroprotective tetrahydrocannabidiol d9-THC d9THC neurochemistry neuroscience | ||||
| 92350 | Capsaicin | 404-86-4 | >95% |
|
2004-04-01 | 15.443406998158 | capsaicin | Capsicum peppers VR1 vanilloid receptors pain heat hot extracts nociceptive burning neurochemistry neuroscience lipid-soluble extracts calcium ca+ ion channels pathways desensitization non-myelinatedpolymomdal c-type nerve fibers | |||
| 10010743 | Capsaicin (technical grade) | 404-86-4 | >60% |
|
2007-11-27 | 6.330511049723 | capsaicin-technical-grade | Capsicum peppers VR1 vanilloid receptors pain heat hot extracts nociceptive burning neurochemistry neuroscience lipid-soluble extracts calcium ca+ ion channels pathways desensitization non-myelinatedpolymomdal c-type nerve fibers | |||
| 10007518 | Capsazepine | 138977-28-3 | >98% |
|
2006-03-29 | 16.283858195212 | capsazepine | vanilloid receptors 1 VR1 transient potential TRP endogenous stimuli tissues injury inflammation pain antagonists capsaicin Ca2+ neonatal rats dorsal root ganglias Chinese hamsters ovary ovaries cells | |||
| 13702 |
Cav1.2 Calcium Channel Monoclonal Antibody (Clone S57- |
- | 2009-11-05 | 1.845323741007 | cav1-2-calcium-channel-monoclonal-antibody-clone-s57-46 | antibodies western blotting blots immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC channels ions fusion proteins gated voltage-gated ligand-gated voltage ligand | |||||
| 13703 |
Cav1.3 Calcium Channel Monoclonal Antibody (Clone S38- |
- | 2009-11-05 | 0.369064748201 | cav1-3-calcium-channel-monoclonal-antibody-clone-s38-8 | antibodies channels ions fusion proteins CACNAID western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC gated voltage-gated ligand-gated voltage ligand | |||||
| 13706 |
Cav1.3 Calcium Channel Monoclonal Antibody (Clone S48A- |
- | 2009-11-12 | 0.369064748201 | cav1-3-calcium-channel-monoclonal-antibody-clone-s48a-9 | antibodies channels ions fusion proteins CACNAID western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC gated voltage-gated ligand-gated voltage ligand | |||||
| 13704 |
Cav3.2 Calcium Channel Monoclonal Antibody (Clone S55- |
- | 2009-11-12 | 0.369064748201 | cav3-2-calcium-channel-monoclonal-antibody-clone-s55-10 | antibodies CACNA1H genes epilepsy up-regulations up regulations upregulations prostate cancers androgen-independent androgen independent western blotting blots WB fusion protein immunohistochemistry IHC immunocytochemistry ICC | |||||
| 13701 |
Cavβ4 Calcium Channel Monoclonal Antibody (Clone S10- |
- | 2009-11-05 | 0.369064748201 | cav-4-calcium-channel-monoclonal-antibody-clone-s10-7 | western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels antibodies epilepsy IGE JME subunits gated voltage-gated ligand-gated ligand voltage | |||||
| 71652 | CAY10401 | 288862-89-5 | >98% |
|
2005-02-02 | 19.017930018416 | cay10401 | FAAH inhibitors analgesics fatty acids amides hydrolases inhibits inhibition hydrolysis hydrolyze CAY-10401 inactivation anandamides AEA arachidonoyl ethanolamides neuroscience neurochemistry | |||
| 72620 | CAY10412 Exclusive | 390824-17-6 | >98% |
|
✓ | 14.724758287292 | cay10412 | endocannabinoids neurotransmitters ligands lipids CB1 CB2 receptors AEA fatty acids neurochemistry neuroscience | |||
| 10004259 | CAY10429 | 22972-55-0 | >98% |
|
2005-02-09 | 15.302817679557 | cay10429 | Abnormal Cannabidiol; Abn-CBD | endocannabinoids cannabidiols abnormal abn-cbd non-CB1 non-CB2 receptors agonists BV-2 microglials hypotensives GPCR neurochemistry neuroscience | ||
| 10009523 |
CAY10429- |
- | ≥99% deuterated product |
|
2007-10-02 | 1.662983425414 | cay10429-d3 | Abnormal Cannabidiol-d3; Abn-CBD-d3 | endocannabinoids cannabidiols abnormal abn-cbd non-CB1 non-CB2 receptors agonists BV-2 microglials hypotensives GPCR neurochemistry neurosciences cannabindoids CB1 CB2 deuterated deuterium mass spectrometry LC-MS GC-MS AbnCBD LC/MS GC/MS | ||
| 10005102 | CAY10435 | 288862-73-7 | >98% |
|
2004-07-06 | 18.830208717004 | cay10435 | fatty acid amide inhibitors FAAH hydrolases inhibition inhibits hydrolysis hydrolyze CAY-10435 1-(Oxazolo[4,5-b]pyridin-2-yl)-1-oxo-dodecane neurochemistry neuroscience | |||
| 10005186 | CAY10441 Exclusive | 221529-58-4 | >98% |
|
✓ | 2004-09-16 | 112.584337016574 | cay10441 | RO1138452 | receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma cyclic AMP cAMP adenylate cyclase 4,5-dihydro-1H-imidazol-2-yl-4-4-isopropoxy benzyl phenylamine atherosclerosis | |
| 10005633 | CAY10448 | - | >98% |
|
2004-10-01 | 7.963632596685 | cay10448 | capsaicin capsicum vanilloids receptors antagonists cannabinoids analgesia anandamides analgesic vanillylamines amides analogs transient potential VR1 pain TRPV1 neurochemistry neuroscience | |||
| 10005913 | CAY10449 Exclusive | - | >98% |
|
✓ | 2004-10-26 | 202.691795580110 | cay10449 | receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma adenylate cyclase cyclic AMP cAMP iloprost athersclerosis CAY 10449 | ||
| 10005072 | CAY10455 | 290374-09-3 | >98% |
|
2004-11-09 | 9.925303867403 | cay10455 | SKM 4-45-1 | anandamides AEAs neurons fatty acid amide hydrolase FAAH analogs arachidonyl ethanolamides transporters acyl fluorescent fluorescence substrates cellular trafficking neurochemistry neuroscience | ||
| 10007955 | CAY10498 | 863202-33-9 | >98% |
|
2006-08-02 | 7.727734806630 | cay10498 | 2-phenyl-amino-N6-endo-norbornyladenine | adenosine receptor antagonist A1 A2A A2B A3 AR G-protein stroke inflammation glaucoma neurodegenerative disease reversine dedifferentiation neurochemistry ophthalmology | ||
| 10008669 | CAY10508 | 878533-35-8 | >98% |
|
2006-08-04 | 43.478629834253 | cay10508 | 1,3-bis(4-bromophenyl)-5-phenyl-Imidazolidine-2,4-dione central peripheral cannabinoids receptors inverse agonists antagonists therapeutic therapy obesity drug dependence CB1 CB2 CP-55,940 | |||
| 10010740 | CAY10550 | 34320-83-7 | ≥98% |
|
2008-07-14 | 5.937016574585 | cay10550 | 3-(4-Nitrophenyl)-1-phenyl-2-pyrazolin-5-one | prion PrPc PrPsc PrPres mad cow disease scrapie creutzfeldt-jakob disease spongigorm encephalopathy radical scavenger inhibitors inhibits inhibition | ||
| 10012565 | CAY10568 | 22913-17-3 | ≥98% |
|
2008-05-28 | 6.248572744014 | cay10568 | Santinamide | TRPV1 QX314 cationic lidocaine capsaicin pain ion channel anesthetics analgesia nociception CAY10568 | ||
| 10010032 | CAY10570 Exclusive | 875014-22-5 | >98% |
|
✓ | 2008-06-03 | 22.081339779005 | cay10570 | FAAH fatty acids amides AEA anandamides CB1 inhibitors inhibits inhibition endocannabinoids hydrolases | ||
| 13281 | CAY10598 Exclusive New | 346673-06-1 | ≥98% |
|
✓ | 2010-05-07 | 28.830165745856 | cay10598 | Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection | ||
| 13358 | CAY10608 Exclusive New | 457897-92-6 | ≥98% |
|
✓ | 2010-04-29 | 0E-12 | cay10608 | N-Methyl-D-aspartate NMDA receptors antagonists glutamate glycine propanolamine NR2B subunit AMPA kainate neuroprotection neurochemistry antagonizes potently selectively non-competitively | ||
| 10010398 |
CB- |
432047-72-8 | ≥98% |
|
2009-06-30 | 38.221719207020 | cb-13 | cannabinoids CB1 CB2 central peripheral receptors agonists pains hyperalgesia blocks blocking CB13 CB 13 | |||
| 301500 | CB1 Receptor Blocking Peptide | - | 17.984397790055 | cb1-receptor-blocking-peptide | Cannabinoid Receptor 1 | cannabis DELTA9-tetrahydrocannabinol .DELTA.9-tetrahydrocannabinol anandamides controls peptides receptors D9-tetrahydrocannabinol antibodies cannabinoids DELTA9-THC D9-THC .DELTA.9-THC western blots blotting IHC immunohistochemistry WB neurochemistry neuroscience | |||||
| 10006590 |
CB1 Receptor (C- |
- |
|
2005-05-10 | 58.582845303867 | cb1-receptor-c-term-polyclonal-antibody | Cannabinoid Receptor 1 | cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC western blots blotting antisera antiserum WB IHC immunohistochemistry neuroscience neurochemistry endocrinology immunoblotting | |||
| 101500 | CB1 Receptor Polyclonal Antibody | - |
|
27.981068139963 | cb1-receptor-polyclonal-antibody | Cannabinoid Receptor 1 Polyclonal Antibody | cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC western blots blotting antisera antiserum WB neuroscience neurochemistry endocrinology immunoblotting | ||||
| 10010116 |
CB- |
869376-63-6 | >98% |
|
2007-10-25 | 22.236309392264 | cb-25 | cannabinoids ligands receptors CB1 CB2 THC anandamides AEA inverse agonists | |||
| 301550 | CB2 Receptor Blocking Peptide | - | 21.819171270718 | cb2-receptor-blocking-peptide | Cannabinoid Receptor 2 | cannabis DELTA9-tetrahydrocannabinol .DELTA.9-tetrahydrocannabinol anandamides controls peptides receptors D9-tetrahydrocannabinol cannabinoids D9-THC .DELTA.9-THC DELTA9-THC immunohistochemistry IHC western blots blotting WB antibodies neurochemistry neuroscience | |||||
| 101550 | CB2 Receptor Polyclonal Antibody | - |
|
31.042093922652 | cb2-receptor-polyclonal-antibody | Cannabinoid Receptor 2 | cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC antisera antiserum western blots blotting WB neuroscience neurochemistry endocrinology immunoblotting IHC immunohistochemistry | ||||
| 10010712 | CB2 Receptor Polyclonal FITC Antibody | - | 2008-01-15 | 33.989281767955 | cb2-receptor-polyclonal-fitc-antibody | Cannabinoid Receptor 2 | cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC antisera antiserum western blots blotting WB neuroscience neurochemistry GPCRs FC flow cytometry immunoblotting IF immunofluorescence | ||||
| 10010117 |
CB- |
- | >98% |
|
2007-10-25 | 26.224817679557 | cb-52 | cannabinoids ligands receptors CB1 CB2 THCs anandamides AEAs partial agonists neutral antagonists | |||
| 13289 |
CB- |
1150586-64-3 | ≥98% |
|
✓ | 2010-05-03 | 56.201583793738 | cb-86 | cannabinoids receptors CB1 CB2 antinociception agonists resorcinol anandamides hybrids CB86 CB 86 partial agonist neural antagonist antinociceptive effects | ||
| 589101 | CGRP (human) EIA Kit | - |
|
171.001381215470 | cgrp-human-eia-kit | Calcitonin Gene-related Peptide (human) EIA Kit; CGRP (human) ELISA Kit | calcitonin peptides measures kits eias enzyme immunoassays ELISAs spi-bio neurochemistry neuroscience spibio A05481 endocrinology assays | ||||
| 589001 | CGRP (rat) EIA Kit | - |
|
343.294198895027 | cgrp-rat-eia-kit | Calcitonin Gene-related Peptide (rat) EIA Kit; CGRP (rat) ELISA Kit | calcitonin peptides measures kits eias enzyme immunoassays ELISAs spi-bio neurochemistry neuroscience spibio A05482 endocrinology assays | ||||
| 10011126 | Clobenpropit (hydrobromide) | 145231-35-2 | >98% |
|
2008-12-04 | 1.456132596685 | clobenpropit-hydrobromide | Carbamimidothioic Acid; VUF-9153 | histamines receptors antagonist GABA neurons brains seizures | ||
| 16851 |
(±)- |
70434-82-1 | ≥98% |
|
2008-12-10 | 36.372038187255 | -cp-47-497 | receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 | |||
| 90084 |
(−)- |
83002-04-4 | >98% |
|
2007-01-15 | 62.252072339600 | -cp-55-940 | CP 55940 CP-55940 CP-55,940 agonists cannabinoids CB1 CB2 THC receptors endocrinology cp55940 cp55,940 neurochemistry | |||
| 13241 |
(±)- |
83003-12-7 | ≥98% |
|
✓ | 2009-05-20 | 20.889805645634 | -cp-55-940 | cannabinoids analgetic pain THC thermal mechanical chemicals receptors CB1 cannabimimetic potent non-selective CP55940 CP-55940 | ||
| 10011388 | Cu/Zn SOD (human) Polyclonal Antibody | - | 23 kDa | 2008-04-03 | 136.142270718232 | cu-zn-sod-human-polyclonal-antibody | SOD1; Cu/Zn Superoxide Dimutase | SOD1 SOD2 SOD3 EC-SOD oxidative stress ROS superoxide antibodies antiserum WB western blots immunoblotting IP EIA IHC immunohistochemistry neurochemistry immunoprecipitation enzyme immunoassays neurochemistry blotting | |||
| 581001 | Cyclic AMP EIA Kit | - |
|
712.046570052688 | cyclic-amp-eia-kit | Adenosine 3',5'-cyclic monophosphate EIA Kit; cAMP EIA Kit; Adenosine 3',5'-cyclic mononucleotide EIA Kit; Cyclic AMP ELISA Kit | cAMP adenosine measures kits eias enzyme immunoassays ELISAs second messengers neurochemistry neuroscience endocrinology assays | ||||
| 581001.1 | Cyclic AMP EIA Kit (Solid Plate) | - |
|
607.625303867403 | cyclic-amp-eia-kit-solid-plate | Adenosine 3',5'-cyclic monophosphate EIA Kit (Solid Plate); Adenosine 3',5'-cyclic mononucleotide EIA Kit (Solid Plate); cAMP EIA Kit (Solid Plate); Cyclic AMP ELISA Kit (Solid Plate) | cAMP adenosine measures kits eias enzyme immunoassays ELISAs second messengers assays | ||||
| 581021 | Cyclic GMP EIA Kit | - |
|
692.909381215469 | cyclic-gmp-eia-kit | Guanosine 3',5'-cyclic mononucleotide EIA Kit; Cyclic GMP ELISA Kit; cGMP EIA Kit; Guanosine 3',5'-cyclic monophosphate EIA Kit | cGMP guanosine measures kits eias enzyme immunoassays ELISAs second messengers neurochemistry neuroscience endocrinology assays | ||||
| 581021.1 | Cyclic GMP EIA Kit (Solid Plate) | - |
|
487.001233885819 | cyclic-gmp-eia-kit-solid-plate | Guanosine 3',5'-cyclic monophosphate EIA Kit (Solid Plate); Guanosine 3',5'-cyclic mononucleotide EIA Kit (Solid Plate); Cyclic GMP ELISA Kit (Solid Plate); cGMP EIA Kit (Solid Plate) | cGMP guanosine measures kits eias enzyme immunoassays ELISAs second messengers assays | ||||
| 10603 |
DARPP- |
- | 2009-10-22 | 0.225127087872 | darpp-32-phospho-thr34-polyclonal-antibody | gamma inhibits inhibitors neurotransmitters WB western blots blotting receptors dopamine cAMP inhibition immunoblotting DARPs DARP32 DARP 32 | |||||
| 90349 |
Decanoyl m- |
72298-61-4 | >98% |
|
✓ | 36.517277032360 | decanoyl-m-nitroaniline | DemNA | FAAH substrates anandamides hydrolases colorimetric cannabinoids aea meta-nitroanilines fatty acids anandamide nitroanilines nitroanalines arachidonoyl ethanolamides ethanolamines neurochemistry neuroscience | ||
| 10007903 |
D- |
6918-49-6 | ≥98% |
|
2008-11-21 | 16.293462246777 | d-erythro-sphingosine-c-20 | sphingosines sphingolipids ceramides C-18 C18 C20 gangliosides brain development neurodegenerations | |||
| 10010575 |
Desmethyltrimebutine- |
- | >99% deuterated product |
|
2008-04-14 | 2.320441988950 | desmethyltrimebutine-d3-hydrochloride | timebutine anesthetic SPI disorders spasmolytic gastrointestinal neurochemistry | |||
| 90235 |
Dihomo- |
150314-34-4 | >98% |
|
10.343035424114 | dihomo-linolenoyl-ethanolamide | endocannabinoids neurotransmitters dihomo-gamma-linolenoyl dihomo-g-linolenoyl dihomo-.gamma.-linolenoyl cannabinergic fatty acids neurochemistry neuroscience ethanolamines ethanolamides | ||||
| 92355 | Dihydrocapsaicin | 19408-84-5 | >98% |
|
5.927521704814 | dihydrocapsaicin | capsicum peppers VR1 receptors non-myelinated polymodal C-type nociceptive nerve fibers calcium ion channels pain pathways CA2+ vanilloid heat-activated neurochemistry hot extracts burning neuroscience lipid-souble desensitization patyways | ||||
| 9000556 | Dimebolin | 3613-73-8 | 98% |
|
2010-01-12 | 124.746025039124 | dimebolin | Dimebon™ | neurodegeneration Alzheimer's diseases Huntington's neuroprotection cognition inhibitors inhibition β-amyloid calcium channels NMDA glutamate receptors mitochondria dimebone dimeboline preparation 84 Dimebolin 12687-54-6 20684-30-4 inhibited | ||
| 10011349 | Dimebolin (hydrochloride) | 97657-92-6 | ≥98% |
|
2010-02-19 | 85.758175890359 | dimebolin-hydrochloride | neurodegeneration Alzheimer's diseases Huntington's neuroprotection cognition inhibitors inhibits inhibition calcium channles β-amyloid β amyloid NMDA glutamate receptors mitochondria dimeboline dimebon neurochemistry neuroscience | |||
| 90310 | Docosahexaenoic Acid | 6217-54-5 | >98% |
|
56.170380601595 | docosahexaenoic-acid | DHA; Cervonic Acid | polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 neurochemistry | |||
| 10005057 |
Docosahexaenoic Acid- |
- | ≥99% deuterated product |
|
2005-03-16 | 66.514917127071 | docosahexaenoic-acid-d5 | DHA-d5; Cervonic Acid-d5 | standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 retinol neuronal membranes neonatal deprivation hypertension | ||
| 10006865 | Docosahexaenoic Acid methyl ester | 2566-90-7 | >98% |
|
2005-09-06 | 33.374751381215 | docosahexaenoic-acid-methyl-ester | Cervonic Acid methyl ester; DHA methyl ester | polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 esters diets dietary supplements hypertension neonatal photoreceptor degeneration retinitis pigmentosa depiration neural tissues retina | ||
| 10006829 |
Docosahexaenoic Acid Quant- |
- |
|
2005-08-08 | 19.107060773480 | docosahexaenoic-acid-quant-pak | DHA Quant-PAK; Cervonic Acid Quant-PAK | Quant-PAKs polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated retinol neuronal membranes neonatal deprivation hypertension neurochemistry packs | |||
| 10007534 | Docosahexaenoyl Ethanolamide Exclusive | 162758-94-3 | >98% |
|
✓ | 2006-02-17 | 24.214447513811 | docosahexaenoyl-ethanolamide | DHEA | neurochemistry neuroscience endocannabinoids brain retina docosahexaenoic acids DHA fatty w-3 .omega.-3 neural tissues ethanolamines ethanolamides arachidonoyl AEA lipids extracts piglets diets rats CB1 receptors shaker-related voltage-gated potassium channels | |
| 9000328 | Docosahexaenoyl Glycine Exclusive | 132850-40-9 | ≥98% |
|
✓ | 2009-01-28 | 12.667983425414 | docosahexaenoyl-glycine | polunsaturated fatty acids PUFAs docosahexaenoic DHA glycines fish oils ALA brain retina neuron neuronal membrane ω-3 α-linolenic | ||
| 10005823 | Docosanoyl Ethanolamide Exclusive | 94109-05-4 | >98% |
|
✓ | 2006-01-11 | 15.930607734806 | docosanoyl-ethanolamide | neurochemistry neuroscience N-acylethanolamides cannabinoids central CB1 peripheral CB2 non-CB receptor-mediated pharmacology memory weight loss appetite neurodegeneration tumor surveillance analgesia inflammation saturated ion channels ethanolamines | ||
| 90385 | Docosatetraenoyl Ethanolamide | 150314-35-5 | >98% |
|
12.927383815405 | docosatetraenoyl-ethanolamide | DEA | endocannabinoids neurotransmitters ethanolamides docosatetraenoic acid fatty acids neurochemistry neuroscience ethanolamines | |||
| 13245 | Donepezil | 120014-06-4 | ≥95% |
|
2010-03-08 | 84.701178637200 | donepezil | Aricept® | acetylcholine neurotransmitters acetylcholinesterase inhibitors inhibits inhibition central nervous system Alzheimer's diseases cognition memory dementia Donezepil signaling signalling AchE CNS behavior (±)-E 2020 (+/-)-E 2020 E2020 | ||
| 10009372 |
Dopamine Transporter (C- |
- | 2006-11-13 | 0E-12 | dopamine-transporter-c-term-polyclonal-antibody | DAT | antibodies proteins diseases antibodies antisera antiserum IHC immunohistochemistry WB western blots blotting c-terminal keyhole limpet hemocyanin KLH accumulation catecholamine biosynthesis markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's dieseases drug abuse chronic administration immunoblotting | ||||
| 10009373 | Dopamine Transporter (Extracellular Loop 2) Polyclonal Antibody | - | 2006-11-13 | 0E-12 | dopamine-transporter-extracellular-loop-2-polyclonal-antibody | DAT (Extracellular Loop 2) | antibodies proteins diseases antibodies antisera antiserum IHC immunohistochemistry WB western blots blotting c-terminal keyhole limpet hemocyanin KLH accumulation catecholamine biosynthesis markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's dieseases drug abuse chronic administration immunoblotting | ||||
| 10009370 |
Dopamine β- |
- | 2006-11-13 | 0E-12 | dopamine-hydroxylase-c-term-human-polyclonal-antibody | DBH | antibodies proteins diseases antibodies antisera antiserum WB western blots blotting beta-hydroxylase neurons dopaminergic noradrenergic catecholamine biosynthesis markers depression schizophrenia parkinson's diseases drugs abuse immunoblotting | ||||
| 10009371 |
Dopamine β- |
- | 2006-11-13 | 0E-12 | dopamine-hydroxylase-n-term-human-polyclonal-antibody | DBH | antibodies proteins diseases antibodies antisera antiserum WB western blots blotting beta-hydroxylase neurons dopaminergic noradrenergic catecholamine biosynthesis markers depression schizophrenia parkinson's diseases drugs abuse immunoblotting | ||||
| 10005516 | Doppel Blocking Peptide | - | 2004-10-01 | 1.698895027624 | doppel-blocking-peptide | antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides proteins diseases GPI glycosylphosphatidylinositol central nervous system male fertility sertoli CNS spermatozoa nonglycosylated oligosaccharides | |||||
| 10005517 | Doppel Polyclonal Antibody | - |
|
2004-09-24 | 9.151933701657 | doppel-polyclonal-antibody | proteins diseases antibodies antisera antiserum GPI glycosylphosphatidylinositol central nervous system male fertility sertoli CNS spermatozoa nonglycosylated oligosaccharides WB western blots blotting IHC immunohistochemistry immunoblotting | ||||
| 10009785 |
Dynamin (Phospho- |
- | 2007-05-24 | 0E-12 | dynamin-phospho-ser774-polyclonal-antibody | phosphopeptide phospho-specific western blots WB antibodies proteins blotting dephosphins phosphorylation synaptic vesicle endocytosis protein kinase 5 immunoblotting | |||||
| 10009786 |
Dynamin (Phospho- |
- | 2007-05-24 | 0E-12 | dynamin-phospho-ser778-polyclonal-antibody | phosphopeptide phospho-specific western blots WB antibodies proteins blotting dephosphins phosphorylation synaptic vesicle endocytosis protein kinase 5 immunoblotting | |||||
| 10010571 |
Entacapone- |
- | >98% |
|
2008-04-14 | 3.055248618785 | entacapone-d10 | Parkinsons dieseases inhibitors inhibits inhibition SPI nitrocatechols catechol-o-methyl blood-brain barrier neurochemistry | |||
| 101740 | EP1 Receptor Polyclonal Antibody | - |
|
50.559510655090 | ep1-receptor-polyclonal-antibody | Prostaglandin E2 Receptor 1; PGE2 Receptor 1 | PGE2 prostaglandins receptors antibodies antisera antiserum western blots blotting wb icc immunocytochemistry neurochemistry immunoblotting | ||||
| 101760 | EP3 Receptor Polyclonal Antibody | - |
|
50.321002367797 | ep3-receptor-polyclonal-antibody | Prostaglandin E2 Receptor 3; PGE2 Receptor 3 | PGE2 prostaglandins receptors antibodies antisera antiserum western blots blotting wb C-terminus WB ICC immunocytochemistry neurochemistry immunoblotting | ||||
| 10012088 |
Ethyl- |
150403-97-7 | ≥95% |
|
2008-08-14 | 11.075138121547 | ethyl-l-nio-hydrochloride | L-N5-(1-Iminobutyl)ornithine hydrochloride | nitric oxide synthase NOS iNOs nNOS selective inhibitors inhibits inhibition | ||
| 10007433 | FABP5 (murine recombinant) | - | >95% | 2005-07-29 | 26.874458563536 | fabp5-murine-recombinant | Epidermal-FABP; Fatty Acid Binding Protein 5; E-FABP | protein-only proteins cytosolic acids lipophilic ligands uptake metabolism cellular membranes intracellular trafficking modulation enzymes lipids metabolic pathways cells growth differentiation antiparallel B .beta. strands barrel prostates bladder carcinomas atherosclerosis endocrinology neurochemistry | |||
| 301600 | Fatty Acid Amide Hydrolase Blocking Peptide | - | 18.751151012891 | fatty-acid-amide-hydrolase-blocking-peptide | Oleamide Hydrolase; FAAH; Anandamide Amidohydrolase | hydrolases peptides hydrolysis controls acids amides WB western blots blotting IHC immunohistochemistry immunoblotting antibodies neurochemistry neuroscience | |||||
| 10010183 | Fatty Acid Amide Hydrolase (human recombinant) | - | 100,000 x g supernatant | 2008-11-05 | 54.928239936858 | fatty-acid-amide-hydrolase-human-recombinant | FAAH (human recombinant) | FAAHs endocannabinoid AEA cannabinoids 2-AG 2AG proteins FAAH-1 acids amides hydrolases | |||
| 101600 | Fatty Acid Amide Hydrolase Polyclonal Antibody | - |
|
38.617099447514 | fatty-acid-amide-hydrolase-polyclonal-antibody | Oleamide Hydrolase; FAAH; Anandamide Amidohydrolase | WB western blots hydrolases antibodies antiserum antisera hydrolysis immunohistochemistry IHC immunoblotting neurochemistry neuroscience blotting | ||||
| 70250 |
(±)- |
5104-49-4 | >99% |
|
121.615055248619 | -flurbiprofen | Ansaid | cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases neurochemistry synthase-1 synthase-2 inhibits 51543-38-5 | |||
| 10600 |
GABAA Receptor δ- |
- | 2009-10-22 | 0.225127087872 | gabaa-receptor-subunit-n-term-polyclonal-antibody | γ-Aminobutyric Acid A Receptor | gamma inhibits inhibitors neurotransmitters WB western blots blotting IP IHC immunoprecipitation immunohistochemistry | ||||
| 10008346 | Gabapentin | 60142-96-3 | >98% |
|
2006-04-20 | 3.560193370165 | gabapentin | Neurontin® | antiepileptic drugs Gamma-aminobutyric acids GABA neurotransmitters receptors spinal cord analogs anticonvulsants analgeics neuropathics pain syndromes Complex Regional types CRPS1 multiple sclerosis dysesthesias cancers HIV infections CNS central nervous systems calcium channels .gamma.-aminobutyric g-aminobutyric neurochemistry | ||
| 10009400 |
Gap- |
- | 2006-12-18 | 1.901473296501 | gap-43-phospho-ser41-polyclonal-antibody | GAP43 development and plasticity neuronal growth cones axonal regeneration knockout animals amplify path finding signals mediate actin phosphorylation kinases C PKC modulates neurotransmitters LTP antibodies antisera antiserum WB western blots IHC immunohistochemistry frozen sections blotting proteins diseases phospho-specific immunoblotting | |||||
| 10007621 | GFAP (human) EIA Kit | - | 2006-07-11 | 8.397790055249 | gfap-human-eia-kit | Glial Fibrillary Acidic Protein (human) EIA Kit | SPI-Bio spibio kits enzyme immunoassays A05188 assays | ||||
| 10006306 | Ghrelin (human acylated) EIA Kit | - |
|
2004-11-10 | 114.416574585635 | ghrelin-human-acylated-eia-kit | Ghrelin (human acylated) ELISA Kit | spi-bio acylated immunoassays obesity growth hormones homeostasis ligands secretagogue A05106 receptors stomach hypothalmic spi-bio spibio A05106 adipokines endocrinology neurochemistry assays ghrelin assay | |||
| 10006307 | Ghrelin (rat acylated) EIA Kit | - |
|
2004-11-10 | 175.312062615101 | ghrelin-rat-acylated-eia-kit | Ghrelin (rat acylated) ELISA Kit | spi-bio acylated immunoassays obesity growth hormones homeostasis ligands secretagogue receptors stomach hypothalmic spibio A05117 adipokines endocrinology neurochemistry assays ghrelin assay | |||
| 10602 |
GluR1 (Phospho- |
- | 2009-10-22 | 0.225127087872 | glur1-phospho-ser831-polyclonal-antibody | Glutamate Receptor Subunit 1 | gamma inhibits inhibitors neurotransmitters WB western blots blotting receptors NMDAR AMPAR kinase immunoblotting | ||||
| 10601 |
GluR1 (Phospho- |
- | 2009-10-22 | 2.026143790850 | glur1-phospho-ser845-polyclonal-antibody | Glutamate Receptor Subunit 1 | gamma inhibits inhibitors neurotransmitters WB western blots immunoblotting receptors NMDA AMPA kinases IHC immunohistochemistry | ||||
| 10011347 |
Glycerophospho- |
201738-25-2 | ≥97% |
|
✓ | 2009-03-13 | 23.463167587477 | glycerophospho-n-arachidonoyl-ethanolamine | Glycerophospho-Arachidonoyl Ethanolamide; Glycerophosphoanandamide; GP-NArE | anandamides arachidonoyl ethanolamide AEA NAE GDE1 cannabinoids neurotransmitters CB1 CB2 glycerophosphodiesterase 1 NAPE N-Acyl Phosphatidylethanolamide | |
| 10011357 |
Glycerophospho- |
201738-24-1 | ≥98% |
|
✓ | 2009-02-20 | 26.663259668509 | glycerophospho-n-oleoyl-ethanolamine | cannabinoids neurotransmitter PPARs neurochemistry neuroscience fatty acids amides hydrolase oleoyl ethanolamides methabolism obesity nutrition diet NAPE N-Acyl Phosphatidylethanolamide | ||
| 10009399 | Glycine Receptor Polyclonal Antibody | - | 2006-12-18 | 0.315706393054 | glycine-receptor-polyclonal-antibody | GLY inhibits inhibitors inhibition inhibitory transmitter brainstem spinal cord ligand-gated ion channels family LGICs chemical neurotransmission chloride conductance membranes hyperpolarization synapses cytoplasmic proteins gephyrin alcohol synaptic clustering NMDAR subunit antibodies antisera antiserum WB western blots blotting proteins diseases immunoblotting IHC immunohistochemistry | |||||
| 13332 |
Glycyl- |
913844-45-8 | ≥98% |
|
2010-01-27 | 81.578635739133 | glycyl-h-1152-hydrochloride | Rho Kinase Inhibitor IV | Rho kinases ROCK-I p160ROCK ROCK-II G protein Rho cytoskeletons adhesions proliferation smooth muscles contraction stem cells inhibitors inhibition inhibited Fasudil hydrochloride ROCK IV | ||
| 10010372 | GW 842166X | 666260-75-9 | >98% |
|
2008-05-23 | 11.112279005524 | gw-842166x | inflammatory pain arthritis neuropathic hyperalgesia CB2 cannabinoids agonists anandamide receptors neurochemistry | |||
| 13205 | Halopemide Exclusive | 59831-65-1 | ≥98% |
|
✓ | 2009-04-21 | 18.747734806630 | halopemide | R34301; NSC 354856 | inhibitors phospholipases D PLD PLD1 PLD2 dopamine receptors inhibits inhibition potent cells DP nueraleptic | |
| 13705 |
HCN1 Cyclic Nucleotide- |
- | 2009-12-01 | 0E-12 | hcn1-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s70-28 | antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-1 HCN 1 | |||||
| 13707 |
HCN2 Cyclic Nucleotide- |
- | 2009-12-01 | 0E-12 | hcn2-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s71-37 | antibodies western blots blotting immunoblotting WB immunohistochemistry IHC ions channels HCN-2 HCN 2 ICC immunocytochemistry immunoprecipitation IP | |||||
| 13708 |
HCN3 Cyclic Neuclotide- |
- | 2009-12-01 | 0E-12 | hcn3-cyclic-neuclotide-gated-channel-monoclonal-antibody-clone-s141-28 | antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-3 HCN 3 | |||||
| 13709 |
HCN4 Cyclic Nucleotide- |
- | 2009-12-02 | 0E-12 | hcn4-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s114-10 | antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-4 HCN 4 hyperpolarization-activated cation gene family hyperpolarization activated activity activates | |||||
| 90342 | Heptadecanoyl Ethanolamide | - | >98% |
|
10.460693677102 | heptadecanoyl-ethanolamide | pea cannabinoids palmitoyl ethanolamides anandamides neurochemistry neuroscience ethanolamines | ||||
| 90082 |
HU- |
112830-95-2 | >98% |
|
26.584623522033 | hu-210-dea-schedule-i-regulated-compound | agonists analogs d9-THC marijuana CB1 CB2 receptors cannabinoids HU210 .DELTA.9-THC delta9-THC neuroscience neurochemistry endocrinology | ||||
| 10006350 |
HU- |
112924-45-5 | >98% |
|
2005-03-30 | 9.809913180741 | hu-211 | Dexanabinol | HU211 endocannabinoids cannabis CB2 pain inflammation NF-kB NF-.kappa.B inhibition antioxidants neurochemistry terpene-based psychomotor DELTA9-THC .DELTA.9-THC D9-THC neuroprotective cannabidiols CB1 inflammatory pharmacology neuroscience neurochemistry | ||
| 90086 |
HU- |
256934-39-1 | >98% |
|
2005-03-16 | 19.336410635298 | hu-308 | endocannabinoids CB2 pain inflammation G-protein coupled receptors agonists hypotensives analgesics anti-inflammatory phenolic .DELTA.9-THC D9-THC CB1 FAAH fatty acid hydrolases substrates selective neuroscience neurochemistry GPCRs HU308 HU 308 cannabinoids | |||
| 10005673 |
HU- |
137252-25-6 | >95% |
|
2005-09-09 | 29.442098572670 | hu-331 | cannabidiols analogs antiproliferative activity endocannabinoids central CB1 peripheral CB2 non-CB receptor-mediated pharmacology receptors memory weight loss appetite neurodegeneration tumor surveillance analgesia inflammation hydroxylquinone antineoplastic human cancer cells lines inhibits inhibitors inhibition growth Raji Jurkat lymphomas in vitro HT-29 colon carcinomas neuroscience neurochemistry cannabinoids | |||
| 10010669 |
Hydroxy Bupropion- |
- | ≥99% deuterated product |
|
2009-04-17 | 0E-12 | hydroxy-bupropion-d9 | aminoketone ketones antideppressant dopamine smoking cessation treatment deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry | |||
| 70280 |
(±)- |
15687-27-1 | >99% |
|
26.169030637870 | -ibuprofen | Motrin | PPAR cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits peroxisome proliferator-activated receptors neurochemistry | |||
| 10137 | Icilin | 36945-98-9 | >98% |
|
2004-04-27 | 12.303443830570 | icilin | AG 3-5 | cooling agent cold receptors CMR1 neurons transient receptors potential VR1 vanilloid receptos TRPM8 neurochemistry neuroscience | ||
| 10215 | IDFP | 615250-02-7 | ≥98% |
|
2009-03-09 | 36.371639042357 | idfp | Isopropyl Dodecylfluorophosphonate | CB1 agonist nerve agent serins organophophorus MAGL inhibitors inhibits inhibition FAAH 2-AG 2AG AEA arachidonic acids MGL inhibitor | ||
| 70275 | IMMA | - | >98% |
|
13.882707182320 | imma | Indomethacin Morpholinylamide; BML-190 | cannabinoids receptors CB2 neuroscience neurochemistry endocrinology | |||
| 70270 | Indomethacin | 53-86-1 | >99% |
|
29.114060773480 | indomethacin | Indocin | cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin synthases synthase-1 synthase-2 PPARs peroxisome proliferator-activated receptors inhibits neurochemistry | |||
| 10005518 | IP Receptor (human) Polyclonal Antibody | - | 2004-10-21 | 21.225132305903 | ip-receptor-human-polyclonal-antibody | Prostaglandin I2 Receptor; Prostacyclin Receptor; PGI2 Receptor | antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors immunoblotting atherosclerosis | ||||
| 160070 | IP Receptor (murine) Polyclonal Antibody | - |
|
2004-05-25 | 21.991111878453 | ip-receptor-murine-polyclonal-antibody | PGI2 Receptor; Prostacyclin Receptor; Prostaglandin I2 Receptor | antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors atherosclerosis neurochemistry immunoblotting | |||
| 10008661 | JP 104 | - | >98% |
|
2006-09-05 | 13.937685696746 | jp-104 | click chemistry probes FAAH fatty acids amides hydrolases inhibits inhibitors inhibition URB598 acyl anandamide AEA esters unsaturated carbamates neurochemistry | |||
| 10008660 | JP83 | - | >98% |
|
2006-08-30 | 13.670527931246 | jp83 | FAAH fatty acids amides hydrolases inhibits inhibitors inhibition URB597 acyl anandamide AEA esters unsaturated carbamates arachidonoyl ethanolamides neurochemistry | |||
| 10009018 | JWH 015 | 155471-08-2 | >98% |
|
2006-10-05 | 49.110268983371 | jwh-015 | agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-g IFN-.gamma. CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 | |||
| 13169 | JWH 018 | 209414-07-3 | ≥98% |
|
2009-03-12 | 49.692032855579 | jwh-018 | cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 | |||
| 9000851 |
JWH 018 4- |
- | ≥98% |
|
✓ | 2010-09-01 | 0E-12 | jwh-018-4-hydroxyindole-metabolite | cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics JWH-018 JWH018 209414-07-3 JWH018-metabolite JWH 018-metabolite one CBs M-1 M1 smoking mixtures spices | ||
| 9000852 |
JWH 018 5- |
- | ≥98% |
|
✓ | 2010-09-01 | 0E-12 | jwh-018-5-hydroxyindole-metabolite | cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBS M-2 M2 | ||
| 9000853 |
JWH 018 6- |
- |
|
✓ | 2010-09-01 | 0E-12 | jwh-018-6-hydroxyindole-metabolite | cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices | |||
| 9000854 |
JWH 018 7- |
- | ≥98% |
|
✓ | 2010-09-01 | 0E-12 | jwh-018-7-hydroxyindole-metabolite | cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite four 4 M4 M-4 smoking mixtures spices | ||
| 13824 |
JWH 018- |
- | ≥99% deuterated product |
|
2010-06-21 | 0E-12 | jwh-018-d9 | cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS | |||
| 9000855 |
JWH 018 N- |
- | ≥98% |
|
✓ | 2010-09-01 | 0E-12 | jwh-018-n-5-hydroxypentyl-metabolite | cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite five 5 CBs M-5 M5 smoking mixtures spices | ||
| 9000856 |
JWH 018 N- |
- | ≥98% |
|
✓ | 2010-09-01 | 0E-12 | jwh-018-n-pentanoic-acid-metabolite | cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices | ||
| 13633 | JWH 019 | 209414-08-4 | ≥98% |
|
2010-01-14 | 67.298560318265 | jwh-019 | cannabinoids CB1 CB2 receptors THC JWH-019 JWH019 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinol cannabinmimetic indoles | |||
| 13170 | JWH 073 | 208987-48-8 | ≥97% |
|
2009-03-02 | 51.317119181546 | jwh-073 | cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 | |||
| 9000861 |
JWH 073 4- |
- | ≥98% |
|
✓ | 2010-09-01 | 0E-12 | jwh-073-4-hydroxyindole-metabolite | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices | ||
| 9000862 |
JWH 073 5- |
- | ≥98% |
|
✓ | 2010-09-01 | 0E-12 | jwh-073-5-hydroxyindole-metabolite | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 2 JWH-073 JWH073 CBs M-2 agonists smoking mixtures spices | ||
| 9000863 |
JWH 073 6- |
- | ≥95% |
|
✓ | 2010-09-01 | 0E-12 | jwh-073-6-hydroxyindole-metabolite | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices | ||
| 9000864 |
JWH 073 7- |
- | 98% |
|
✓ | 2010-09-01 | 0E-12 | jwh-073-7-hydroxyindole-metabolite | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 4 JWH-073 CBs JWH073 M-4 mixtures smoking spices | ||
| 9000868 |
JWH 073- |
- | ≥99% deuterated product |
|
2010-08-10 | 0E-12 | jwh-073-d7 | deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-073 JWHs JWH073 JWH73 JWH-73 JWH 73 cannabinoids CB1 receptors CB2 peripheral central | |||
| 9000865 |
JWH 073 N- |
- | ≥98% |
|
✓ | 2010-09-01 | 0E-12 | jwh-073-n-5-hydroxybutyl-metabolite | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices M-5 | ||
| 9000866 |
JWH 073 N- |
- | ≥98% |
|
✓ | 2010-09-01 | 0E-12 | jwh-073-n-butanoic-acid-metabolite | cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH 073 Metabolite 6 JWH-073 CBs JWH073 M-6 smoking mixtures spices | ||
| 13634 | JWH 250 | 864445-43-2 | ≥98% |
|
2010-01-14 | 75.255792964475 | jwh-250 | cannabinoids CB1 CB2 receptors THC JWH-250 JWH250 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinols indoles | |||
| 10578 | JWH 251 New | 864445-39-6 | ≥98% |
|
2010-08-20 | 11.685128913443 | jwh-251 | cannabinoids receptors JWHs JWH-251 JWH251 WIN55212-2 WIN 55212-2 CB1 CB2 cannabimimetics urine forensics | |||
| 13158 | JZL 184 Exclusive | 1101854-58-3 | ≥97% |
|
✓ | 2009-01-26 | 159.274762430939 | jzl-184 | 2-AG 2AG MAGL inhibitors inhibits inhibition endocannabinoid pains analgesia MGL inhibitor JZL184 JZL-184 | ||
| 13668 | JZL 195 Exclusive | - | ≥98% |
|
✓ | 2010-02-10 | 119.371514769074 | jzl-195 | fatty acid amide hydrolase FAAH monoacylglycerol lipase MAGL endocannabinoids arachidonoyl ethanolamide AEA 2-arachidonoylglycerol 2-AG inibitors inhibition inhibits PF-3845 PF 3845 PF3845 JZL195 JZL-195 JZL184 antinociception pain catalepsy hypomotility CB1 2AG | ||
| 13711 |
KCNQ1 Potassium Channel Monoclonal Antibody (Clone S37A- |
- | 2009-12-02 | 0E-12 | kcnq1-potassium-channel-monoclonal-antibody-clone-s37a-10 | antibodies western blots WB immunoblotting blotting immunoprecipitation IP immunohistochemistry IHC KCNQ-1 IKs inner ears cardiac muscles channels Kv7.1 hyperpolarization-activated cation hyperpolarization activated activity activate | |||||
| 13712 |
KCNQ2 Potassium Channel Monoclonal Antibody (Clone S26A- |
- | 2009-12-02 | 0E-12 | kcnq2-potassium-channel-monoclonal-antibody-clone-s26a-23 | antibodies western blots WB immunoblotting blotting immunoprecipitation IP immunohistochemistry IHC KCNQ-2 IKs inner ears cardiac muscles channels Kv7.1 familial neonatal convulsions benign hyperpolarization activated | |||||
| 13713 |
KCNQ4 Potassium Channel Monoclonal Antibody (Clone S43- |
- | 2009-12-02 | 0E-12 | kcnq4-potassium-channel-monoclonal-antibody-clone-s43-6 | antibodies western blots blotting immunoblotting immunoprecipitation immunocytochemistry ICC IP KCNQ-4 proteins retigabine hyperpolarization-activated hyperpolarization activated activity activate cation antioconvuslants anti-convulsantd | |||||
| 10009280 |
L- |
174627-50-0 | >98% |
|
2007-09-13 | 11.112279005524 | l-759-633 | L759633 cannabinoids receptors agonists CB1 CB2 endocrinology neurochemistry | |||
| 13248 |
L- |
59-92-7 | ≥95% |
|
2010-02-03 | 47.870748299320 | l-dopa | 3,4-Dihydroxyphenylalanine; Pardopa; Levodopa; Syndopa | dopamine neurotransmitter locomotion Parkinson's disease stroke dopaflex (-)-dopa 3,4-dihydroxyphenylalanine parda larodopa laradopa levopa veldopa weldopa dopalina dopastral doparkine dopasol 3-(3,4-dihydroxyphenyl)-alanine ledopa DOPA phenylalanines alanines 1-(-)-dopa | ||
| 10010572 |
Lercanidipine- |
- | >99% deuterated product |
|
2008-04-14 | 0E-12 | lercanidipine-d3-hydrochloride | SPI blocker calcium dihydropyrine neurochemistry | |||
| 13353 | Lignoceric Acid | 557-59-5 | ≥98% |
|
2009-08-04 | 0.170552486187 | lignoceric-acid | FL 88 | fatty acids brains development cerebrosides sphingomyelin myelin galactoplipids peroxisome Zellweger cerebro-hepato-renal cerebrohepatorenal syndromes X chromosomes X-chromosomes chromosome-linked linked adrenoleukodystrophy lignin FL88 L 88 FL-88 L-88 | ||
| 90155 | Linoleoyl Ethanolamide | 68171-52-8 | >98% |
|
20.762187845303 | linoleoyl-ethanolamide | cannabinoids neurotransmitter ethanolamides fatty acids neurochemistry neuroscience ethanolamines linoleyl | ||||
| 9000553 |
Linoleoyl Ethanolamide- |
- | ≥99% deuterated product |
|
✓ | 2010-01-13 | 70.033626940278 | linoleoyl-ethanolamide-d4 | cannabinoids neurotransmitter ethanolamides fatty acids neurochemistry neuroscience ethanolamines linoleyl deuterateds deuteriums LC-MS GC/MS GC-MS mass spectrometry standards LC/MS MS | ||
| 9000326 | Linoleoyl Glycine | 2764-03-6 | ≥98% |
|
2008-10-29 | 4.611809392265 | linoleoyl-glycine | N-Linoleoyl Glycine; LinGly; Glycine Linoleamide | arachidonyl glycine fatty acids AEA FAAH inhibits inhibitor inhibition anandamide homologs | ||
| 90195 | Mead Acid Ethanolamide | 169232-04-6 | >98% |
|
15.784716223004 | mead-acid-ethanolamide | cannabinoids neurotransmitter CB1 CB2 receptors ligands acids ethanolamides eicosatrienoyl fatty acids neurochemistry neuroscience ethanolamines | ||||
| 10009518 |
MEK 1 (Phospho- |
- | 2007-01-12 | 0E-12 | mek-1-phospho-thr292-polyclonal-antibody | antibodies WB western blot MEK 1 phosphorylation MAP kinase cell growth differentiation threonine tyrosine phospho-specific blotting immunoblotting | |||||
| 10009517 |
MEK 1 (Phospho- |
- | 2007-01-11 | 0E-12 | mek-1-phospho-thr386-polyclonal-antibody | antibodies WB western blot MEK 1 phosphorylation MAP kinase cell growth differentiation threonine tyrosine phospho-specific blotting immunoblotting | |||||
| 600180 |
Melanocortin- |
- |
|
2010-01-05 | 30.470564763658 | melanocortin-3-receptor-step-reporter-assay-kit-luminescence | MC3R | MC-3R melanocortins petides hormones proopiomelanocortins pituitary CNS central nervous systems skin placenta tissues MCR receptors G protein-coupled GPCRs cAMP Adenosine 3',5' cyclic mononucleotides messenger signal transduction pathways melanocortin-3 hypothalmus homeostasis fat lean mass hyperphagia MC4R melanocortin-4 adiposity MC3R-knockout mice mouse murine fatty acids oxidations blood pressure hypertension obesity glucose metabolisms insulin insensitivity agonists ligands Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening a-MSH alpha-MSH α-MSH | |||
| 10006355 |
Melanocortin- |
- |
|
2005-08-03 | 24.438929558011 | melanocortin-4-receptor-polyclonal-antibody | MC4R | antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry melanocortins melanogenesis steroidogenesis sexual functions inflammations appetite regulations energy homeostasis G-proteins coupled receptors GPCRs MC1R MC2R MC3R MC5R transcripts brain genetic studies heteozygous mutations human obesity mammalian unglycosylated SDS-PAGE endocrinology immunoblotting | |||
| 600190 |
Melanocortin- |
- |
|
2010-01-05 | 30.470564763658 | melanocortin-4-receptor-step-reporter-assay-kit-luminescence | MC4R | MC-4R melanocortins petides hormones proopiomelanocortins pituitary CNS central nervous systems skin placenta tissues MCR receptors G protein-coupled GPCRs cAMP Adenosine 3',5' cyclic mononucleotides messenger signal transduction pathways melanocortin-3 hypothalmus homeostasis fat lean mass hyperphagia MC4R melanocortin-4 adiposity MC3R-knockout mice mouse murine fatty acids oxidations blood pressure hypertension obesity glucose metabolisms insulin insensitivity agonists ligands sexual function antagonists fever suppression inflammatory mediators in vivo Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening a-MSH alpha-MSH α-MSH | |||
| 70660 | Methyl Arachidonyl Fluorophosphonate | - | >98% |
|
81.200978689818 | methyl-arachidonyl-fluorophosphonate | MAFP | phospholipases inhibitors cPLA2 iPLA2 MAFP fatty acids neuroscience neurochemistry | |||
| 13775 |
Methyl- |
- |
|
2010-04-27 | 0E-12 | methyl-cpg-binding-protein-2-polyclonal-antibody | MeCP2 | antibodies domains cytosines dinucleotides methylations DNA proteins mammalian MED1 MeCP2 PCM1 MBDs MBDs MBD-1 MBD-2 MBD-3 MBD-4 MBD2 MBD3 MBD4 MBD 2/3 MBD-2/3 MBD 1 MBD 2 MBD 3 MBD 4 MBD2-3 MBD 2-3 | |||
| 70662 |
Methyl α- |
- | >98% |
|
36.863858195212 | methyl-linolenyl-fluorophosphonate | MLnFP | PLA2s phospholipases A2 FAAH fatty acids amides hydrolase inhibitors cannabinoids CB receptors antagonists analogs MAFP MaLnFP M.alpha.LnFP MalphaLnFP alpha-linolenyl .alpha.-linolenyl neurochemistry neuroscience | |||
| 70664 |
Methyl γ- |
- | >98% |
|
31.524906077348 | methyl-linolenyl-fluorophosphonate | MγLnFP | PLA2s phospholipases A2 FAAH fatty acids amides hydrolases inhibitors cannabinoids CB receptor antagonists M.gamma.LnFP MgammaLnFP analogs MAFP neurochemistry neuroscience | |||
| 10212 | Monoacylglycerol Lipase (FL) Polyclonal Antibody New | - |
|
2010-03-23 | 122.169116022099 | monoacylglycerol-lipase-fl-polyclonal-antibody | MAGL | WB western blots hydrolases antibodies antiserum antisera hydrolysis immunohistochemistry IHC immunoblotting MGL monoacylglycerol neuroscience neurochemistry MAGL monoglycerol blotting | |||
| 10007812 | Monoacylglycerol Lipase (human recombinant) | - | >95% |
|
2008-04-01 | 110.429965469613 | monoacylglycerol-lipase-human-recombinant | MAGL; MGL | neuroscience neurochemistry 2-AG endocannabinoids hydrolases proteins MAGLs MGLs recombinant | ||
| 705192 | Monoacylglycerol Lipase Inhibitor Screening Assay Kit | - |
|
2009-10-22 | 70.744733326111 | monoacylglycerol-lipase-inhibitor-screening-assay-kit | MAGL; MGL | neuroscience neurochemistry inhibitors inhibiting inhibition inhibits endocannabinoids serines hydrolases pain obesity monoglycerol | |||
| 100035 | Monoacylglycerol Lipase Polyclonal Antibody | - |
|
54.149196383726 | monoacylglycerol-lipase-polyclonal-antibody | MAGL | WB western blots hydrolases antibodies antiserum antisera hydrolysis immunohistochemistry IHC immunoblotting MGL monoacylglycerol neuroscience neurochemistry MAGL monoglycerol blotting | ||||
| 10009566 | Monoacylglycerol Lipase Western Ready Control | - | Whole cell lysate | 2007-01-31 | 14.884763658686 | monoacylglycerol-lipase-western-ready-control | MGL; MAGL | hormone-sensitive lipases HSL kidney spleen heart liver testis stomach brain lung adrenal gland keletal muscle adipose tissue neurochemistry | |||
| 10230 |
(+)- |
24570-49-8 | ≥95% |
|
2010-05-06 | 0E-12 | -muscarine-iodide-salt | neurochemistry 300-54-9 2438-77-9 poisonous mushroom acetylcholine G proteins Alzheimer's disease signal transduction L-muscarine Amanita muscaria | |||
| 13667 | Muscimol New | 2763-96-4 | ≥98% |
|
2010-05-28 | 0.582453038674 | muscimol | Pantherine; Agarin | γ-aminobutyric acid GABA neurotransmitters GABAA GABAC GABAB agonists benzodiazepines memory neurochemistry neuroscience | ||
| 10007704 |
N- |
183718-75-4 | >98% |
|
✓ | 2007-02-02 | 7.486464088398 | n-3-hydroxyphenyl-arachidonoyl-amide | 3-HPAA | neurochemistry neuroscience AM404 anologs N-(4-hydroxyphenyl)-arachidonoylamides AEA ethanolamides cycloxygenase-1 cyclooxygenase-2 COX-1 COX-2 inhibits inhibitors inhibition N-(3-hydroxyphenyl)-Arachidonoylamide 3-HPA | |
| 10014 |
N- |
178603-78-6 | >98% |
|
2004-04-13 | 10.728784530386 | n-ac-tyr-val-ala-asp-cmk | Ac-YVAD-CMK | inhibitors inhibits interleukins neuroprotective cerebral ischemia inhibition selective irreversible interleukin-1.beta.converting enzyme ICE Caspase-1-IL-1.beth. IL1beta neuroprotective cerebral ischemia alaninamides neurochemistry chloromethyl ketones | ||
| 10009737 |
NAPE- |
- | 2007-04-16 | 0.980386740332 | nape-pld-blocking-peptide | peptides WB western blots blotting IHC immunohistochemistry ICC immunocytochemistry N-acylethanolamines NAEs inflammatory regulations apoptosis tissues degenerations biosynthesized membranes phospholipid-dependent pathway enzymes enzymatic hydrolysiscatalyzing phospholipases D subtypes mRNA and proteins activity brain kidney testis neuroscience neurochemistry | |||||
| 10158 |
N- |
- | >98% |
|
2004-03-04 | 8.895103591159 | n-arachidonoyl-3-hydroxy-aminobutyric-acid | NAG-3H-ABA | amino acids bovines brains glycines congeners NAGly suppress responses pain NAG3HABA neurochemistry neuroscience | ||
| 90057 |
N- |
199875-69-9 | >98% |
|
15.821620626151 | n-arachidonoyl-dopamine | NADA | analogs capsaicin arachidonic acids amides VR1 receptors vannilloids cannabinoids aada cb1 cb2 analgesic N-arachidonoyl-dopamine neurochemistry neuroscience | |||
| 10007431 |
N- |
- | ≥99% deuterated product |
|
2005-08-10 | 6.448232044199 | n-arachidonoyl-dopamine-d8 | NADA-d8 | deuterateds analogs capsaicin arachidonic acids amides VR1 receptors vannilloids cannabinoids ada cb1 cb2 analgesic arachidonoyl-dopamine neurochemistry neuroscience deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry | ||
| 90065 |
N- |
401941-73-9 | >98% |
|
2004-04-19 | 15.429640883977 | n-arachidonoyl-l-alanine | NALA | amino acids bovines brains glycines congeners NAGly suppress responses pain neurochemistry neuroscience | ||
| 10005455 |
N- |
187224-29-9 | >98% |
|
2004-08-11 | 7.359131089904 | n-arachidonoyl-l-serine | ARA-S | endocannabinoids antagonists cannabidiols neuroprotective neurotransmitters hypotensive effects antagonize antagonist neurochemistry neuroscience | ||
| 10005537 |
N- |
- | >98% |
|
✓ | 2004-11-18 | 13.430236779794 | n-arachidonoyl-taurine | bovine brain NADA dopamine ARA-S ARAS N-arachidonoyl-L-serine lipidomics mass spectrometry MS rats N-fatty acyl amides amino acids neurochemistry neuroscience TRPV1 TRPV4 FAAH | ||
| 90067 |
N- |
128201-89-8 | >98% |
|
2004-02-26 | 4.679378453038 | n-arachidonoyl-aminobutyric-acid | NAGABA | amino acids bovines brains glycines congeners NAGly suppress responses pain neurochemistry neuroscience | ||
| 10007517 |
N- |
- | >98% |
|
2006-07-31 | 35.758627992633 | n-arachidonyl-maleimide | NAM | neurochemistry neuroscience 2-AG 2-arachidonoyl glycerol MGL MAGL monoacylglycerol lipase monoglycerol inhibition inhibits inhibitor pain inflammation anxiety endocannabinoids anandanides 2AG fatty acids CB1 CB2 central peripheral | ||
| 13718 |
Nav1.7 Sodium Channel Monoclonal Antibody (Clone S68- |
- | 2009-12-04 | 0.647727272727 | nav1-7-sodium-channel-monoclonal-antibody-clone-s68-6 | antibodies channels ions western blots blotting immunoblotting immunoprecipitation WB IP immunocytochemistry ICC pain sensitivity insensitivity sodiums voltage-gated voltage gated | |||||
| 10007739 |
N- |
702638-84-4 | >98% |
|
2006-08-04 | 14.824551104972 | n-cyclohexanecarbonylpentadecylamine | endocannabinoids neurons acidic PEAase palmitoyl ethanolamides amidases anandamides AEA fatty acyls inhibits inhibitors inhibition arachidonoyl neurochemistry neuroscience FAAH hydrolase | |||
| 10008317 |
N- |
- | >98% |
|
2006-08-16 | 14.225103591160 | n-cyclohexanecarbonyltetradecylamine | FAAH AEA anandamide PEAase inhibitor PEA palmitoylethanolamides ararchidonoyl acidic fatty acids amide hydrolases amidase inhibits inhibition | |||
| 10005851 |
N- |
72298-63-6 | >98% |
|
2004-12-07 | 31.444813535911 | n-decanoyl-p-nitroaniline | DepNA | FAAH substrates anandamides hydrolases colorimetric cannabinoids aea para-nitroanalines fatty acids anandamide arachidonoyl ethanolamides neurochemistry neuroscience anilide | ||
| 10010574 |
N- |
294882-33-0 | >99% |
|
2008-04-14 | 2.320441988950 | n-desmethyltrimebutine-hydrochloride | SPI trimebutine metabolites anesthetics disorders spasmolytic gastrointestinal neurochemistry | |||
| 10007288 |
N- |
- | >98% |
|
2005-12-29 | 1.439019337016 | n-docosanoyl-taurine | neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH | |||
| 10004184 | NESS 0327 Exclusive | 494844-07-4 | >98% |
|
✓ | 2008-05-27 | 35.890121546960 | ness-0327 | neurochemistry neuroscience cannabinoids antagonist CB1 CB2 SR 141716A rimonabant WIN 55212-5 pain obesity | ||
| 10007286 |
N- |
807370-75-8 | >98% |
|
2005-12-21 | 1.568610891870 | n-lignoceroyl-taurine | neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH | |||
| 10607 | NMDA Receptor NR1 Subunit Monoclonal Antibody | - | 2009-10-26 | 0.225127087872 | nmda-receptor-nr1-subunit-monoclonal-antibody | inhibits inhibitors neurotransmitters WB western blots blotting receptors ion channels glutamate | |||||
| 10608 | NMDA Receptor NR2A Subunit Polyclonal Antibody | - | 2009-10-26 | 0.225127087872 | nmda-receptor-nr2a-subunit-polyclonal-antibody | inhibits inhibitors neurotransmitters WB western blots blotting receptors ion channels glutamate inhibition immunoprecipitation IP IHC Immunohistochemistry | |||||
| 10009759 |
NMDA Receptor NR2B Subunit (Phospho- |
- | 2007-02-09 | 1.279926335175 | nmda-receptor-nr2b-subunit-phospho-tyr1252-polyclonal-antibody | antibodies WB western blots phospho-specific NMDA receptor NMDAR phosphorylation NR2B blotting immunoblotting | |||||
| 10009760 |
NMDA Receptor NR2B Subunit (Phospho- |
- | 2007-02-09 | 1.279926335175 | nmda-receptor-nr2b-subunit-phospho-tyr1336-polyclonal-antibody | antibodies WB western blots phospho-specific NMDA receptor NMDAR phosphorylation NR2B blotting immunoblotting | |||||
| 10009761 |
NMDA Receptor NR2B Subunit (Phospho- |
- | 2007-02-22 | 2.366482504604 | nmda-receptor-nr2b-subunit-phospho-tyr1472-polyclonal-antibody | antibodies WB western blots phospho-specific NMDA receptor phosphorylation NR2B blotting immunoblotting | |||||
| 10609 | NMDA Receptor NR2B Subunit Polyclonal Antibody | - | 2009-10-26 | 0.225127087872 | nmda-receptor-nr2b-subunit-polyclonal-antibody | N-methyl-D-aspartate Receptor | inhibits inhibitors neurotransmitters WB western blots immunoblotting receptors ion channels glutamate IP IHC immunohistochemistry immunoprecipitation | ||||
| 10007287 |
N- |
- | >98% |
|
2005-12-29 | 1.568610891870 | n-nervonoyl-taurine | neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH | |||
| 360870 | nNOS Electrophoresis Standard | - | >95% | 4.282578268877 | nnos-electrophoresis-standard | ncNOS; Neuronal Nitric Oxide Synthase; NOS I | western blots immunoblotting bNOS synthases standards constitutive antibodies neurochemistry | ||||
| 160870 | nNOS Polyclonal Antibody | - | 14.094389195826 | nnos-polyclonal-antibody | ncNOS; Neuronal Nitric Oxide Synthase; NOS I | synthases Western blots brain bNOS neurotransmitters memory blotting constitutive human neurons antibodies WB ICC immunocytochemistry IHC immunohistochemistry antisera antiserum immunoprecipitation IP neurochemistry immunoblotting | |||||
| 60870 | nNOS (rat recombinant) | - | cell lysate 100,000 x g supernatant | 37.909471191792 | nnos-rat-recombinant | ncNOS; Neuronal Nitric Oxide Synthase; NOS I | neuronal enzymes constitutive nitric oxide synthase bNOS neurochemistry | ||||
| 60875 |
nNOS (rat recombinant) - |
- | >95% | 26.499019337016 | nnos-rat-recombinant-purified | ncNOS; Neuronal Nitric Oxide Synthase; NOS I | neuronal enzymes constitutive nitric oxide synthase bNOS neurochemistry | ||||
| 10009632 | nNOS Western Ready Control | - | 2007-05-30 | 12.205193370166 | nnos-western-ready-control | NOS I; ncNOS | Western blotting WB citrulline nomenclature tissue neuronal brain N-terminus PSD-95 PSD-96 PZD neurochemistry | ||||
| 10115 |
N- |
105955-11-1 | >98% |
|
7.964005524862 | n-oleoyl-dopamine | ODA | VR1 agonists CB1 receptors analogs vanilloids cannabinoids analgesic amides N-oleoyldopamine inhibits inhibitors inhibition 5-lipoxygenases 5-LOs binding selective FAAH hydrolases fatty acid neurochemistry neuroscience | |||
| 90269 |
N- |
2601-90-3 | >98% |
|
7.503259668508 | n-oleoyl-glycine | precursor oleoylamide fatty acids neurochemistry neuroscience oleoylglycine oleoyl-glycine | ||||
| 10005609 |
N- |
52514-04-2 | ≥98% |
|
✓ | 2005-01-05 | 14.042209944751 | n-oleoyl-taurine | endocannibinoids fatty amides oleamides taurines amino-acyls lipidomics profiling fatty acids neurochemistry neuroscience TRPV1 TRPV4 FAAH | ||
| 781001 | NOS Activity Assay Kit | - | 117.077044198894 | nos-activity-assay-kit | iNOS eNOS nNOS nitric oxide synthases activity radiolabeled arginine inducible neuronal endothelial citrulline kits assays | ||||||
| 10007697 |
N- |
136181-87-8 | >98% |
|
2005-11-23 | 4.826464088398 | n-palmitoyl-dopamine | PALDA | N-acyls fatty anologs N-araachidonoyl NADA N-oleoyl ODA bovine brains amides palmitic acids hybrids anandamides neurotransmitter pathways inactive vanilloid receptors 1 VR1 ligands hyperalgesics nocifensives responses in vivo entourage effects neurochemistry | ||
| 10009020 |
N- |
2441-41-0 | ≥98% |
|
2009-12-01 | 4.937348066298 | n-palmitoyl-glycine | N-Hexadecanoyl-Glycine; PalGly | pain inflammation AEA anandamides DRG nociception calcium influx arachidonoyl amides glycines | ||
| 10005611 |
N- |
83982-06-3 | >98% |
|
2005-02-16 | 12.289068666140 | n-palmitoyl-taurine | endocannabinoids fatty amides oleamides bovine brain lipidomics rat amino-acyl neurochemistry | |||
| 70590 |
NS- |
123653-11-2 | >98% |
|
106.847286317841 | ns-398 | cyclooxygenases inhibitors NSAIDs COX-2 nonsteroidal anti-inflammatory drugs cox2 pghs2 pghs-2 prostaglandins synthases synthase-2 inhibits selective ns398 selectivity neurochemistry | ||||
| 10005610 |
N- |
63155-80-6 | >98% |
|
2005-02-09 | 11.965864246250 | n-stearoyl-taurine | endocannabinoids fatty amides oleamides amino-acyl bovine brain rat lipidomics neurochemistry neuroscience TRPV1 TRPV4 FAAH | |||
| 10032 |
N- |
259143-19-6 | >98% |
|
13.326762430939 | n-linolenoyl-tyrosine | NALT | neurochemistry neuroscience fatty acids neurotransmitters dopamine CNS central nervous system anti-Parkinson's anti-Parkinsons diseases endocrinology | |||
| 80587 |
Nω- |
137361-05-8 | >98% |
|
14.944537292817 | n-propyl-l-arginine | nNOS NOS selective inhibitors arginine nitric oxide synthase neurochemistry | ||||
| 10006803 |
O- |
317321-41-8 | >98% |
|
2005-09-12 | 17.105911602209 | o-1602 | abnormal cannabidiols CB1 CB2 receptors vasorelaxation neurochemistry neuroscience central cannabinoids peripheral selective antagonists nonendothelium-dependant vasodilation nitric oxides NOs inhibits inhibitors inhibition vasorelaxant | |||
| 10006804 |
O- |
35482-50-9 | >97% |
|
2005-09-12 | 0.884493554327 | o-1821 | abnormal cannabidiol central cannabinoids peripheral CB1 CB2 receptors vasorelaxation neurochemistry neuroscience antagonists synthetic regioisomer endothelium dependent vasodilation | |||
| 10004914 |
O- |
536697-79-7 | >98% |
|
2005-09-09 | 3.982550644567 | o-1918 | antagonists abnormal cannabinoids cannabidiols cannabidiol-mediated synthetic regioisomers CB1 CB2 responsiveness psychotropics activity induces endothelium-dependent vasodilations NO-independent nitric oxides mechanisms analogs endothelial receptors inhibits inhibition inhibitors vasorelexants in vitro blocks induced activations PI3-kinases Akt pathway umbilical vein cells neuroscience neurochemistry O1918 0-1918 | |||
| 10009195 |
O- |
- | >98% |
|
2007-07-12 | 1.392265193370 | o-2545-hydrochloride | cannabinoids water soluble agonists receptors CB1 CB2 lipophilic surfactants 874745-42-3 murine models intravenously IV 02545 intracerebroventricularly endocrinology neurochemistry | |||
| 91050 |
O- |
443129-35-9 | >98% |
|
38.711696132596 | o-arachidonoyl-ethanolamine-hydrochloride | Virodhamine (hydrochloride); O-AEA HCl; Arachidonic Acid-(2-aminoethyl)-ester (hydrochloride) | endocannabinoids anandamides tetrahydrocannabinoids THC CB1 CB2 receptors arachidonoyl ethanolamides ligand ethanolamines neurochemistry neuroscience esters antagonists | |||
| 10010547 |
O- |
439146-24-4 | >98% |
|
✓ | 2008-03-31 | 43.893867403314 | o-arachidonoyl-glycidol | 2-AG 2-arachidonoyl glycerol 2-oleoylglycerol N-arachidonoylethanolamine anandamide AEA FAAH endocannabinoid obesity pain neurodegenerative diseases monoacylglycerol lipase inhibits inhibitors inhibitions MAGL MGL | ||
| 90265 | Oleoyl Ethanolamide | 111-58-0 | >98% |
|
42.939094853549 | oleoyl-ethanolamide | Oleic Acid Ethanolamide; OEA | cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides | |||
| 10007823 |
Oleoyl Ethanolamide- |
- | ≥99% deuterated product |
|
2006-03-06 | 69.649184182236 | oleoyl-ethanolamide-d2 | OEA-d2; Oleic Acid Ethanolamide-d2 | GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides | ||
| 9000552 |
Oleoyl Ethanolamide- |
- | ≥99% deuterated product |
|
✓ | 2010-01-12 | 100.628998218902 | oleoyl-ethanolamide-d4 | Oleic Acid Ethanolamide-d4; OEA-hydroxyethyl-1,1,2,2-d4 | cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides deuterateds deuteriums MS mass spectrometry CBs LC-MS OEAs LC/MS GC/MS G-MS standards PPAR brain tissue neurochemistry neuroscience | |
| 10005459 | Oleoyl Ethyl Amide Exclusive | 85075-82-7 | >98% |
|
✓ | 2004-07-21 | 30.474806629834 | oleoyl-ethyl-amide | N-Ethyloleamide; OEtA | endocannabinoids analogs FAAH fatty acid amide hydrolase analgesic inhibitors inhibitor inhibition acyl PEAase anxiolytic inhibits selective selectivity neuroscience neurochemistry | |
| 71650 | Oleoyl Oxazolopyridine | 288862-58-8 | >98% |
|
9.502314917127 | oleoyl-oxazolopyridine | CAY10400 | FAAH fatty acid amide hydrolases inhibitors inhibition inhibits hydrolysis hydrolyze CAY-10400 neuroscience neurochemistry | |||
| 62640 | Oleyl Trifluoromethyl Ketone | 177987-23-4 | >98% |
|
3.640883977900 | oleyl-trifluoromethyl-ketone | OTK | Trifluoromethyl ketone inhibitors inhibits analogs oleic fatty acids neurochemistry neuroscience | |||
| 90262 | Olvanil | 58493-49-5 | >98% |
|
8.260755064456 | olvanil | NE 19550; N-Vanillyloleamide | capsaicin capsicum vanilloids receptors agonists cannabinoids analgesia anandamides analgesic vanillylamines amides analogs neurochemistry neuroscience | |||
| 10171 |
OMDM- |
- | >98% |
|
2004-02-05 | 14.419019337016 | omdm-1 | (S)-N-oleoyl Tyrosinol | endocannabinoids inhibitors AEA lipids anandamides analogs selective selectivity inhibits inhibition R-tyrosinol amides (R)-tyrosinol oleic acid reuptake OMDM1 neurochemistry neuroscience | ||
| 10179 |
OMDM- |
- | >98% |
|
2004-02-05 | 12.187425414365 | omdm-2 | (R)-N-oleoyl Tyrosinol | endocannabinoids inhibitors AEA lipids anandamides analogs selective selectivity inhibits inhibition R-tyrosinol amides (R)-tyrosinol oleic acid reuptake OMDM2 neurochemistry neuroscience | ||
| 300000 |
Optineurin (C- |
- | 8.080939226519 | optineurin-c-term-blocking-peptide | NRP; FIP-2 | western blots blotting WB peptides controls FIP2 apoptosis OPTN c-terminus 14.7k interacting protein-2 TNFalpha TNF.alpha. TNF-alpha TNF-.alpha. tumornecrosis factor neurochemistry neuroscience | |||||
| 100000 |
Optineurin (C- |
- |
|
17.322099447513 | optineurin-c-term-polyclonal-antibody | NRP; FIP-2 | apoptosis signaling transduction signalling 14.7k interacting protein-2 nemo-related proteins WB western blots blotting cell death glaucoma IOP intraocular pressure neurochemistry neuroscience CTerm ophthalmology immunoblotting | ||||
| 300002 | Optineurin (INT) Blocking Peptide | - | 2.320441988950 | optineurin-int-blocking-peptide | NRP; FIP-2 | receptors controls peptides antibodies FIP2 WB western blot blotting 14.7K interacting protein-2 neurochemistry neuroscience | |||||
| 100002 | Optineurin (INT) Polyclonal Antibody | - |
|
11.561602209944 | optineurin-int-polyclonal-antibody | NRP; FIP-2 | apoptosis signaling transduction signalling neurochemistry neuroscience fip2 tumor necrosis factors tnf glaucoma IOP intraocular pressure WB western blots blotting cell death 14.7k interacting protein-2nemo-related ophthalmology immunoblotting | ||||
| 10008642 |
oxy- |
- | >98% |
|
2007-09-06 | 15.306648250460 | oxy-arachidonoyl-ethanolamide | oxy-Anandamide; oxy-AEA | oxyanadamide arachidonylethanolamide AEA THC marijuana CB1 CB2 endocannabinoids receptors | ||
| 90350 | Palmitoyl Ethanolamide | 544-31-0 | ≥98% |
|
38.161230008723 | palmitoyl-ethanolamide | Palmidrol; PEA | endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines | |||
| 10007824 |
Palmitoyl Ethanolamide- |
- | ≥99% deuterated product |
|
2006-03-06 | 50.447127071823 | palmitoyl-ethanolamide-d4 | Palmidrol-d4; PEA-7,7,8,8-d4 | GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cyclic cAMP ethanolamides anandamides AEA fatty acids neurochemistry ethanolamines | ||
| 9000551 |
Palmitoyl Ethanolamide- |
- | ≥99% deuterated product |
|
✓ | 2010-01-20 | 67.671417170920 | palmitoyl-ethanolamide-d4 | Palmidrol-d4; PEA-hydroxyethyl-1,1,2,2-d4 | endocannabinoids CB2 neurotransmitters receptors ligands PEAs N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines LC-MS GC-MS mass spetrometry standards deuterateds deuterium MS LC/MS GC/MS cannabinoids | |
| 9000573 |
Palmitoyl Ethanolamide- |
- | ≥99% deuterated compound |
|
✓ | 2010-03-04 | 152.147240882029 | palmitoyl-ethanolamide-d5 | PEA-15,15,16,16,16-d5; Palmidrol-d5 | endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines LC-MS GC-MS mass spetrometry standards deuterateds deuterium MS LC/MS GC/MS CBs | |
| 91354 |
Palmitoyl N- |
189939-61-5 | >98% |
|
9.723812154696 | palmitoyl-n-isopropylamide | PIA | cannabinoids FAAH fatty acid amide hydrolase inhibits inhibitors inhibition ethanolamides palmitoyl-n-isopropylamide PEA neurochemistry neuroscience synthetic analogs hydrolysis ethanolamines | |||
| 62175 | Palmitoyl Serinol | 126127-31-9 | >98% |
|
39.264558011049 | palmitoyl-serinol | endocannabinoids 2PG CB1 receptors synthases FAAH fatty acids amides analogs hydrolases 2-PG glycerols adenyl cyclase inhibits inhibition re-uptake reuptake neurochemistry neuroscience | ||||
| 62650 | Palmityl Trifluoromethyl Ketone | 141022-99-3 | >98% |
|
35.143093922652 | palmityl-trifluoromethyl-ketone | PTK | ketones inhibitors analogs palmitic fatty acids inhibits inhibition lipoxygeanses LOs neurochemistry neuroscience | |||
| 10010907 |
PF- |
898235-65-9 | >98% |
|
2008-03-26 | 9.965125371865 | pf-622 | FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain fatty acids amides hydrolases neurochemistry | |||
| 10010908 |
PF- |
959151-50-9 | >98% |
|
2008-03-25 | 17.691780437896 | pf-750 | FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain neurochemistry | |||
| 71655 | PHOP | 288862-83-9 | >98% |
|
2005-02-02 | 19.981503551696 | phop | Phenyl hexanoyl oxazolopyridine; CAY10402 | FAAH fatty acids amides hydrolases inhibits inhibitors inhibition cannabinoids CB1 CB2 hydrolysis hydrolyze CAY-10402 TGH triacylglycerols neurochemistry neuroscience | ||
| 13663 | Pregabalin New | 148553-50-8 | ≥95% |
|
2010-08-10 | 2.633812154696 | pregabalin | PD 144723; CI 1008; Lyrica | GABA neurotransmitter receptors brain spinal cords analogs anticonvulsant analgesic pains inhibitors inhibits inhibition seizures gabapentin neocortex neuropathic pain voltage-dependent calcium channels γ-Aminobutyric acid | ||
| 589751 | Prion Protein EIA Kit | - |
|
17.627071823204 | prion-protein-eia-kit | Prion Protein ELISA Kit | proteins mad cow diseases bovine spongiform scrapie Creutzfeldt-jakob neurodegeneration measures kits eias enzyme encephalopathy immunoassays ELISAs BSE spi-bio spibio A05201 assays | ||||
| 10009030 | Prion Protein Monoclonal Antibody (11C6) | - | 2006-07-11 | 5.937016574585 | prion-protein-monoclonal-antibody-11c6 | proteins antibodies antisera antiserum spi-bio spibio A03212 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry | |||||
| 189710 | Prion Protein Monoclonal Antibody (12F10) | - | 14.831307550644 | prion-protein-monoclonal-antibody-12f10 | proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob A3221 neurodegeneration antibodies antisera antiserum neurochemistry neuroscience spi-bio spibio WB western blots blotting immunoblotting IHC immunohistochemistry | ||||||
| 189750 | Prion Protein Monoclonal Antibody (308) | - | 6.622099447513 | prion-protein-monoclonal-antibody-308 | proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum neurochemistry neuroscience spi-bio spibio A03200 WB western blots blotting immunoblotting IHC immunohistochemistry | ||||||
| 189760 | Prion Protein Monoclonal Antibody (8G8) | - | 8.674401473296 | prion-protein-monoclonal-antibody-8g8 | proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antisera antiserum antibodies WB western blots blotting IHC immunohistochemistry neurochemistry neuroscience spi-bio spibio A03220 immunoblotting | ||||||
| 10009034 | Prion Protein Monoclonal Antibody (BAR221) | - | 2006-07-11 | 8.402920284135 | prion-protein-monoclonal-antibody-bar221 | proteins antibodies antisera antiserum spi-bio spibio A03222 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry IHC immunohistochemistry | |||||
| 10009035 | Prion Protein Monoclonal Antibody (BAR224) | - | 2006-07-11 | 13.507498026834 | prion-protein-monoclonal-antibody-bar224 | proteins antibodies antisera antiserum spi-bio spibio A03211 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry IHC immunohistochemistry | |||||
| 10009036 | Prion Protein Monoclonal Antibody (BAR233) | - | 2006-07-11 | 6.361089187056 | prion-protein-monoclonal-antibody-bar233 | proteins antibodies antisera antiserum spi-bio spibio A03223 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry | |||||
| 10009037 | Prion Protein Monoclonal Antibody (BAR236) | - | 2006-07-11 | 6.361089187056 | prion-protein-monoclonal-antibody-bar236 | proteins antibodies antisera antiserum spi-bio spibio A03224 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry | |||||
| 189720 |
Prion Protein Monoclonal Antibody (SAF- |
- | 50.746593001841 | prion-protein-monoclonal-antibody-saf-32 | proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt- jakob neurodegeneration antibodies antisera antiserum saf32 neurochemistry neuroscience spi-bio spibio A03202 WB western blots blotting immunoblotting IHC immunohistochemistry Enzyme-linked immunosorbent assays FC flow cytometry | ||||||
| 189730 |
Prion Protein Monoclonal Antibody (SAF- |
- | 6.622099447513 | prion-protein-monoclonal-antibody-saf-53 | proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf53 neurochemistry neuroscience spi-bio spibio A03203 Enzyme-linked immunosorbent assays FC flow cytometry | ||||||
| 189740 |
Prion Protein Monoclonal Antibody (SAF- |
- | 6.622099447513 | prion-protein-monoclonal-antibody-saf-54 | proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf54 neurochemistry neuroscience spi-bio spibio A03204 IHC immunohistochemistry | ||||||
| 189755 |
Prion Protein Monoclonal Antibody (SAF- |
- | 7.648250460405 | prion-protein-monoclonal-antibody-saf-61 | proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf61 neurochemistry neuroscience spi-bio spibio A03205 Enzyme-linked immunosorbent assays FC flow cytometry | ||||||
| 189770 |
Prion Protein Monoclonal Antibody (SAF- |
- | 11.752854511970 | prion-protein-monoclonal-antibody-saf-70 | proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt- A03206 jakob neurodegeneration antibodies SAFTO WB western blots blotting antisera antiserum neurochemistry neuroscience spi-bio spibio immunoblotting | ||||||
| 189765 |
Prion Protein Monoclonal Antibody (SAF- |
- | 13.805156537753 | prion-protein-monoclonal-antibody-saf-83 | proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf83 neurochemistry neuroscience spi-bio spibio A03207 WB western blots blotting immunoblotting Enzyme-linked immunosorbent assays FC flow cytometry | ||||||
| 189775 |
Prion Protein Monoclonal Antibody (SAF- |
- | 12.779005524861 | prion-protein-monoclonal-antibody-saf-84 | proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf84 neurochemistry neuroscience spi-bio spibio A03208 WB western blots blotting immunoblotting IHC immunohistochemistry | ||||||
| 13621 | Pristimerin Exclusive | 1258-84-0 | ≥98% |
|
✓ | 2010-03-08 | 143.627627566680 | pristimerin | Celestrol methyl ester; NSC 99281 | monoacylglycerol lipases MAGLs monoglycerol MGLs cannabinoids 2-arachidonoyl glycerol 2-AG inhibitor 2-Picenecarboxylic acids | |
| 12010 | Prostaglandin D2 | 41598-07-6 | >99% |
|
109.955638428484 | prostaglandin-d2 | PGD2 | Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry | |||
| 312010 |
Prostaglandin D2- |
- | ≥99% deuterated product |
|
41.322983425414 | prostaglandin-d2-d4 | PGD2-d4 | GC/MS deuterium isotopes PGD2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience | |||
| 10007272 |
Prostaglandin D2- |
- | ≥99% deuterated compound |
|
2009-02-26 | 29.197265193370 | prostaglandin-d2-d4-lipid-maps-ms-standard | PGD2-d4 | GC/MS deuterium isotopes PGD2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience MS mass spectrometry standards | ||
| 10010123 |
Prostaglandin D2- |
- | ≥99% deuterated product |
|
2007-10-25 | 54.458176795580 | prostaglandin-d2-d9 | PGD2-d9 | GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience allergy asthma | ||
| 512031 | Prostaglandin D2 EIA Kit New | - |
|
2010-07-19 | 0E-12 | prostaglandin-d2-eia-kit | PGD2 ELISA Kit | PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions | |||
| 12012 | Prostaglandin D2 Ethanolamide | 398138-28-8 | >96% |
|
33.406519337016 | prostaglandin-d2-ethanolamide | PGD2-EA | anandamides ethanolamides cannabinoids PGD2 prostaglandins AEA neurochemistry neuroscience ethanolamines prostamides | |||
| 10007203 | Prostaglandin D2 Ethanolamide Lipid Maps MS Standard | 398138-28-8 | >96% | 2008-10-29 | 24.403701657458 | prostaglandin-d2-ethanolamide-lipid-maps-ms-standard | PGD2-EA | anandamides ethanolamides cannabinoids PGD2 prostaglandins AEA neurochemistry neuroscience ethanolamines prostamides GC LC mass spectrometry MS standards | |||
| 512041 | Prostaglandin D2 Express EIA Kit New | - |
|
2010-07-19 | 0E-12 | prostaglandin-d2-express-eia-kit | PGD2 Express ELISA Kit | PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions | |||
| 10192 | Prostaglandin D2 serinol amide | - | >98% |
|
2004-05-13 | 37.320806629834 | prostaglandin-d2-serinol-amide | PGD2-SA | PGD2 vasodilation prostaglandins brain sleep platelets aggregation anandamides serinols amides cannabinoids AEA | ||
| 10007684 |
Prostaglandin D Synthase (lipocalin- |
- |
|
✓ | 2008-06-09 | 11.181801954951 | prostaglandin-d-synthase-lipocalin-type-human-eia-kit | Lipocalin-PGDS ELISA Kit; L-PGDS EIA Kit | EIAs ELISAs Assays sandwich immunometric homodimer glycosylation catalyzes prostaglandins PGH2 PGD2 carrier proteins lipid-like molecules neurochemistry retinoids thyroid hormones body fluids cerebrospinal seminal plasma PTGDS beta-trace b-trace .beta.-trace betatrace btrace lpgds l-pgds assays | ||
| 10004342 |
Prostaglandin D Synthase (lipocalin- |
- | 2004-03-04 | 7.779060773481 | prostaglandin-d-synthase-lipocalin-type-human-monoclonal-antibody-clone-10a5 | Lipocalin-PGDS; L-PGDS | prostaglandins inhibitors renal failure synthases lpgds antibodies antisera antiserum wb ihc western blots blotting immunohistochemistry b-trace beta-trace .beta.-trace l-pgds immunoblotting | ||||
| 10006788 |
Prostaglandin D Synthase (lipocalin- |
- | >95% | 2005-03-23 | 63.418876611417 | prostaglandin-d-synthase-lipocalin-type-human-recombinant | L-PGDS; Lipocalin-PGDS | prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds | |||
| 10009741 | Prostaglandin D Synthase (lipocalin type; human) Western Ready Control | - | 2007-04-30 | 6.499425414364 | prostaglandin-d-synthase-lipocalin-type-human-western-ready-control | L-PGDS; Lipocalin-PGDS | GST lpgds l-pgds western blot WB neurochemistry hL-PGDS hLPGDS | ||||
| 10004344 |
Prostaglandin D Synthase (lipocalin- |
- | 2004-03-10 | 10.926308387745 | prostaglandin-d-synthase-lipocalin-type-murine-polyclonal-antibody | Lipocalin-PGDS; L-PGDS | prostaglandins inhibitors renal failure synthases antibodies antisera antiserum wb ihc western blots blotting immunohistochemistry lpgds l-pgds immunoblotting | ||||
| 10006787 |
Prostaglandin D Synthase (lipocalin- |
- | >95% | 2005-03-23 | 67.890623984400 | prostaglandin-d-synthase-lipocalin-type-murine-recombinant | L-PGDS; Lipocalin-PGDS | prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds | |||
| 160003 |
Prostaglandin D Synthase (lipocalin- |
- |
|
41.494462860651 | prostaglandin-d-synthase-lipocalin-type-polyclonal-antibody | L-PGDS; Lipocalin-PGDS | antibodies human pgds synthases western blots blotting prostaglandins pgd2 antisera antiserum wb lpgds l-pgds immunoblotting | ||||
| 10010548 |
Prostaglandin D Synthase (lipocalin- |
- | >95% | ✓ | 2008-07-01 | 73.268771780705 | prostaglandin-d-synthase-lipocalin-type-rat-recombinant | L-PGDS; Lipocalin-PGDS | prostaglandins PGH2 beta-trace b-trace proteins assays neurochemistry rL-PGDS rlPGDS .beta.-trace beta-trace b-trace recombinant human cerebrospinal fluid PGs CSF GST-tags GST-tagged N-terminal lpgds l-pgds | ||
| 13012 | Prostaglandin E1 Ethanolamide | 210976-81-1 | >98% |
|
42.412688766114 | prostaglandin-e1-ethanolamide | PGE1-EA; Alprostadil Ethanolamide | anandamides ethanolamides cannabinoids PGE1 prostaglandins AEA neurochemistry neuroscience ethanolamines prostamides | |||
| 14012 | Prostaglandin E2 Ethanolamide Exclusive | 194935-38-1 | >98% |
|
✓ | 49.427658839779 | prostaglandin-e2-ethanolamide | PGE2-EA; Dinoprostone Ethanolamide; Prostamide E2 | anandamides ethanolamides cannabinoids PGE2 prostaglandins AEA analogs neurochemistry neuroscience ethanolamines prostamides | ||
| 10007212 | Prostaglandin E2 Ethanolamide Lipid Maps MS Standard | 194935-38-1 | >98% |
|
2008-11-05 | 31.497309392265 | prostaglandin-e2-ethanolamide-lipid-maps-ms-standard | Dinoprostone Ethanolamide; Prostamide E2; PGE2-EA | anandamides ethanolamides cannabinoids PGE2 prostaglandins AEA analogs neurochemistry neuroscience ethanolamines prostamides GC-MS GC/MS LC-MS LC/MS mass spectromatory standards | ||
| 10193 | Prostaglandin E2 serinol amide Exclusive | - | ≥98% |
|
✓ | 2004-03-03 | 45.789033149171 | prostaglandin-e2-serinol-amide | PGE2-SA | PGE2SA cannabinoids agonists CB1 receptors analogs 2-glyceryl neurochemistry neuroscience | |
| 160630 |
Prostaglandin I Synthase Monoclonal Antibody (Clone isn- |
- | 6.660718232044 | prostaglandin-i-synthase-monoclonal-antibody-clone-isn-1 | Prostacyclin Synthase; PGIS; PGI Synthase | synthases endothelium PGI2 prostaglandins antibodies antisera antiserum Bovine PGI synthase atherosclerosis neurochemistry IP immunoprecipitation IHC immunohistochemistry | |||||
| 100023 | Prostaglandin I Synthase (murine) Polyclonal Antibody | - |
|
2004-06-30 | 9.757941988950 | prostaglandin-i-synthase-murine-polyclonal-antibody | PGIS; Prostacyclin Synthase; PGI Synthase | antibodies antisera antiserum western blots blotting wb IHC immunohistochemistry prostaglandins prostacyclins synthases receptors atherosclerosis immunoblotting | |||
| 160640 | Prostaglandin I Synthase Polyclonal Antibody | - | 7.291952117864 | prostaglandin-i-synthase-polyclonal-antibody | Prostacyclin Synthase; PGIS; PGI Synthase | PGIS prostacyclin synthases endothelium Western blots PGI2 prostaglandins blotting antisera antiserum immunoprecipitation IP antibodies atherosclerosis WB immunoblotting | |||||
| 10011435 | PSD95 Monoclonal Antibody (Clone 6G6) | - | 0.814917127072 | psd95-monoclonal-antibody-clone-6g6 | Postsynaptic Density Protein 95 | antibodies ICC WB western blots immunocytochemistry proteins neurochemistry neurons memory learning neuronal AMPA immunoblotting autism TARPs blotting | |||||
| 10011436 | PSD95 Monoclonal Antibody (Clone 7E3) | - | 2008-05-07 | 0.814917127072 | psd95-monoclonal-antibody-clone-7e3 | Postsynaptic Density Protein 95 | antibodies WB western blots proteins neurochemistry neuronal neurons synapse memory learning PSD-95 immunoblotting receptors TARPs AMPA autism PSD 95 blotting | ||||
| 10009506 | PSD95 Polyclonal Antibody | - | 2007-01-03 | 1.799830004250 | psd95-polyclonal-antibody | Postsynaptic Density Protein of 95 | antibodies WB western blot PDZ domain glutamate receptors signaling proteins synapse NMDAR phosphorylation proteins signalling blotting immunoblotting | ||||
| 10008594 | PSN632408 | 857652-30-3 | >98% |
|
2006-08-01 | 40.699189686925 | psn632408 | GPR119 SNORF25 agonists oleoylethanolamide OEA obesity appetite food intake GPCR G protein-coupled receptors PSN632408 weight gain pancreas gastrointestinal tract brain endocrinology neurochemistry | |||
| 90070 |
R- |
157182-49-5 | >98% |
|
23.478737174428 | r-1-methanandamide | (R)-(+)-Arachidonyl-1'-Hydroxy-2'-Propylamide | cannabinoids neurotransmitters ligand AEA lipids CB1 CB2 receptor anandamide analogs agonists neurochemistry neuroscience | |||
| 10004281 |
R- |
- | >98% |
|
2004-08-20 | 17.777476979741 | r-1-methanandamide-phosphate | R-1MAP; (R)-(+)-Arachidonyl-1'-Hydroxy-2'-Propylamide Phosphate | endocannabinoids neurotransmitters ligands AEA lipids CB1 CB2 receptors anandamides analogs agonists phosphates LPA lysophatidic acids neurochemistry neuroscience R1 | ||
| 90074 |
R- |
- | >98% |
|
13.702859116022 | r-2-methanandamide | (R)-(-)-Arachidonyl-2'-Hydroxy-1'-Propylamide | cannabinoids neurotransmitter AEA lipids CB1 CB2 receptors anandamide analogs neurochemistry neuroscience | |||
| 10491 |
(R)- |
444912-51-0 | ≥98% |
|
✓ | 2010-05-27 | 5.797237569061 | -r-am1241 | (+)-AM1241 | cannabinoids CB2 receptors CB1 agonists inverse agonists antinociception pains SR144528 rimonabant CBs | |
| 10012554 | Resolvin D1 Exclusive | 872993-05-0 | ≥95% |
|
✓ | 2008-06-06 | 349.448176795580 | resolvin-d1 | RvD1; 17(S)-Resolvin D1 | EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins | |
| 70255 |
(R)- |
51543-40-9 | >99% |
|
2004-06-11 | 5.618524072612 | -r-flurbiprofen | E-7869; Tarenflurbil; Flurizan | cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits inhibition neurochemistry | ||
| 10009411 | Ribosomal S6 Kinase 2 Polyclonal Antibody | - | 2006-11-28 | 1.222375690607 | ribosomal-s6-kinase-2-polyclonal-antibody | RSK2 | wb western blotting blots antibodies p90 kinases RSK1 RSK2 RSK3 RSK4 downstream members extracellular signal-regulated ERK/MAPK cascade humans Coffin-Lowry syndrome mental retardation growth deficits defects tonic regulation GPCRs G protein-coupled signalling immunoblotting | ||||
| 9000484 | Rimonabant | 168273-06-1 | ≥98% |
|
2009-06-17 | 35.504088397789 | rimonabant | SR141716 | SR 141716A SR141716A CB1 inverse agonists anti-obesity immunomodulation anti-proliferation appetite suppressants receptors weight control medication cannabinoids anti-proliferative immunodulatory | ||
| 10011132 | Rolipram | 61413-54-5 | ≥98% |
|
2008-12-16 | 5.263867403315 | rolipram | ZK 62711; SB 95952 | inhibits inhibitor inhibition phosphodiesterase PDE4 cAMP inflammation leukocyte LPS TNF monocytes C5a LTC4 eosinophil neurons bones loss | ||
| 90353 |
R- |
142128-47-0 | >98% |
|
9.200679233019 | r-palmitoyl-1-methyl-ethanolamide | R-1 PMA | PEA AEA ethanolamides R-1-PMA cannabinoids analogs (R)-methyl ethanolamines inhibitors inhibits CB2 receptors neurochemistry neuroscience | |||
| 90357 |
R- |
179951-56-5 | >98% |
|
8.892569060773 | r-palmitoyl-2-methyl-ethanolamide | RP-2ME | PEA cannabinoids analogs anandamides methanandamides CB2 receptors ethanolamides inhibits inhibitors (R)-N-(2-hydroxypropyl)-hexadecanamide FAAH fatty acids hydrolases agonists neurochemistry neuroscience ethanolamines | |||
| 10009227 |
(R)- |
656827-86-0 | >98% |
|
2007-09-05 | 1.938480662983 | -r-slv-319 | CB1 CB2 receptors cannabinoids antagonists inflammation | |||
| 90072 |
S- |
- | >98% |
|
13.702859116022 | s-1-methanandamide | (S)-(-)-Arachidonyl-1'-Hydroxy-2'-Propylamide | cannabinoids neurotransmitters ligand AEA lipids CB1 CB2 receptors anandamides analogs agonists neurochemistry neuroscience | |||
| 90076 |
S- |
- | >98% |
|
18.505791896869 | s-2-methanandamide | (S)-(+)-Arachidonyl-2'-Hydroxy-1'-Propylamide | cannabinoids neurotransmitter ligand AEA lipid CB1 CB2 receptors anandamide analogs agonists neurochemistry neuroscience | |||
| 10490 |
(S)- |
444912-53-2 | ≥98% |
|
✓ | 2010-05-27 | 5.797237569061 | -s-am1241 | (-)-AM1241 | cannabinoids CB2 receptors CB1 agonists inverse agonist antinociception pains SR144528 rimonabant CBs | |
| 10096 | SB 242084 (hydrochloride) New | 1049747-87-6 | ≥98% |
|
2010-06-29 | 0E-12 | sb-242084-hydrochloride | 181632-25-7 serotonins 5-hydroxytryptamines 5-HT neurotransmitters neuroscience receptors gut central nervous system antagonists 5-HT2C dopamine adrenergic receptors brain anxiolytic neurochemistry CNS | |||
| 14060 |
SC- |
19395-87-0 | >96% |
|
62.012845303867 | sc-19220 | PGE2 antagonists antinociceptives EP1 receptors selective prostaglandins SC19220 neurochemistry | ||||
| 10009312 |
SKF- |
130495-35-1 | >98% |
|
2007-01-19 | 14.202375690607 | skf-96365-hydrochloride | calcium antagonists voltage-gated inhibits inhibitors inhibition acetylcholine-induced depolarization smooth muscles platelets neutrophils SFK9635 Ach-induced HCl neurochemistry | |||
| 10009226 |
(±)- |
362519-49-1 | >98% |
|
✓ | 2007-01-16 | 21.522808471454 | -slv-319 | CB1 CB2 Receptors Cannabinoids Antagonists Inflammations inflammatory neurochemistry lipophilic ligands | ||
| 10006518 |
S- |
- | 2005-11-29 | 169.407329074585 | s-nitrosylated-protein-detection-kit | SNO Detection | NOs nitric oxides synthases oxidation oxidative reactive nitrogen species RNS thiol SH groups signalling proteins kits measures measurements S-nitrosation nitrosation S-nitrosylation nitrosylation assays | ||||
| 700330 | Sphingomyelinase Inhibitor Screening Assay Kit | - |
|
2010-02-09 | 90.860927587085 | sphingomyelinase-inhibitor-screening-assay-kit | assays kits measures measuring measurementsphingomyelinases SMases hydrolases enzymes sphingolipids metabolisms DNase I superfamily phosphocholines ceramides cellular cells stress pathophysiological lysosomal digestion ceramide-mediated signal transductions cytokine-induced apoptosis differentiation immune inflammatory lipoproteins aggregation vessels atherogenesis intracellular cholesterols trafficking acidic neutral proliferation depressive disorders neurodegenerative disorders strokes Alzheimer's dementia diseases therapeutics cleavage conjugates free thiols | ||||
| 10009022 |
(S)- |
464213-10-3 | >98% |
|
✓ | 2007-08-16 | 3.310856353590 | -s-slv-319 | CB1 CB2 receptors cannabinoids antagonists inflammation obesity neurochemistry inflammatory neuro-inflammatory neuroinflammatory (S)-SLV319 disorders ligands | ||
| 90245 | Stearoyl Ethanolamide | 111-57-9 | >98% |
|
17.034316298342 | stearoyl-ethanolamide | Stearic Acid Ethanolamide; Ceramid | anandamides N-acyl ethanolamines PLD fatty acids neurochemistry neuroscience ethanolamides | |||
| 583751 | Substance P EIA Kit | - |
|
259.141616022100 | substance-p-eia-kit | Substance P ELISA Kit | Substance-P Sub-P neurokinin measures kits eias enzyme immunoassays ELISAs pain endocrinology neurochemistry neuroscience assays | ||||
| 10606 | Synapsin I Polyclonal Antibody | - | 2009-10-23 | 0.225127087872 | synapsin-i-polyclonal-antibody | gamma inhibits inhibitors neurotransmitters WB western blots blotting enzymes synthesis plasticity brain IHC IF IP immunohistochemistry immunoprecipitation immunofluorescence | |||||
| 10605 | Synapsin I Polyclonal Antibody (neat serum) | - | 2009-10-23 | 0.225127087872 | synapsin-i-polyclonal-antibody-neat-serum | gamma inhibits inhibitors neurotransmitters WB western blots blotting enzymes synthesis plasticity brain | |||||
| 13830 | Synthetic Cannabinoid HPLC Mixture New | - | ≥95% for each compound | 2010-05-13 | 0E-12 | synthetic-cannabinoid-hplc-mixture | cannabinoids CBs endocannabinoids cannabidiols CP-47,497 cp 47,497 47,497-c8-homolog CP-47,497-C8 homolog analog CP-55,940 cp47,497 cp55,940 cp 55,940 HU-331 HU331 HU 331 HU308 HU 308 HU-308 JWH-015 jwh015 jwh 015 jwh 018 jwh018JWH-018 JWH-200 jwh200 jwh 200 jwh 250 jwh250 JWH-019 Win-55212-2 Jwh-250 win 55212-2 win55212 2 synthetic spices mixes | ||||
| 70240 | Tacrine (hydrochloride) | 1684-40-8 | >98% |
|
6.119208103130 | tacrine-hydrochloride | Romotal; Cognex | acetylcholinesterase inhibitors Alzheimer's disease serotonin noradrenalin AChE enzyme immunoassay reagents neurochemistry neuroscience | |||
| 10009911 | Tangeritin | 481-53-8 | ≥98% |
|
2008-12-16 | 5.877348066298 | tangeritin | Ponkanetin; NSC 618905; NSC 53909 | flavone cancers tumors cholesterol atherosclerosis ERKs p38 MAPKs JNKs AKTs LDLs triacylglycerol estradiol MDR1 pregnane X receptors IL-1 IL1 IL 1 melanoma insulinoma | ||
| 10011127 | Thioperamide Maleate | 148440-81-7 | ≥98% |
|
2009-03-26 | 0.278453038674 | thioperamide-maleate | histamines H3 receptors antagonists seizures GABA 110-16-7 106243-16-7 selective croses blood-brain barrier | |||
| 13623 | Topiramate New | 97240-79-4 | ≥98% |
|
2010-08-17 | 318.890193370166 | topiramate | TPM; Topamax®; RWJ 17021; McN 4853; Epitomax | anticonvulsant seizures epilepsy migraine headaches McN-4853 McN4853 RWJ-17021 RWJ17021 epitoma topamac topimax topina topomax 1103510-60-6 | ||
| 10011659 | Trolox | 53188-07-1 | ≥98% |
|
2008-12-02 | 339.668715469613 | trolox | 6-hydroxy-2,5,7,8-tetramethylchroman-2-Carboxylic Acid | antioxidants vitamins E oxidative injury injuries neurodegeneration aging cancers adjunctive | ||
| 10009398 |
Tryptophan Hydroxylase (Phospho- |
- | 2006-12-18 | 0.959944751381 | tryptophan-hydroxylase-phospho-ser260-polyclonal-antibody | TPH | TPH260 hydroxylases catalyzes 5-hydroxylation biosynthesis indoleamines serotonin melatonin brain mammals neurons Raphe nuclei pineal gland neurotransmitter phosphorylation cyclic AMP cAMP-dependent kinases PKA Ca2+/calmodulin kinase II CaM K II phosphorylates antibodies antisera antiserum WB western blots blotting proteins diseases phospho-specific immunoblotting | ||||
| 10009397 |
Tryptophan Hydroxylase (Phospho- |
- | 2006-12-18 | 0.767955801105 | tryptophan-hydroxylase-phospho-ser58-polyclonal-antibody | TPH | TPH58 hydroxylases catalyzes 5-hydroxylation biosynthesis indoleamines serotonin melatonin brain mammals neurons Raphe nuclei pineal gland neurotransmitter phosphorylation cyclic AMP cAMP-dependent kinases PKA Ca2+/calmodulin kinase II CaM K II phosphorylates antibodies antisera antiserum WB western blots blotting proteins diseases phospho-specific immunoblotting | ||||
| 10009396 | Tryptophan Hydroxylase Polyclonal Antibody | - | 2006-12-13 | 0.552486187845 | tryptophan-hydroxylase-polyclonal-antibody | TPH | hydroxylases catalyzes biosynthesis serotonin melatonin brain mammals neurons Raphe nuclei pineal gland antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry frozen sections proteins diseases immunoblotting | ||||
| 10009412 |
Tyrosine Hydroxylase (Phospho- |
- | 2006-11-28 | 1.222375690607 | tyrosine-hydroxylase-phospho-ser19-polyclonal-antibody | TH | wb western blotting blots if immunofluorescence ihc immunohistochemistry antibodies rate-limiting enzymes synthesis catecholamines dopamine norepinephrine markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's diseases drug abuse signaling phosphorylation phospho-specific regulation cells identification immunoblotting | ||||
| 10009413 |
Tyrosine Hydroxylase (Phospho- |
- | 2006-11-28 | 1.629834254143 | tyrosine-hydroxylase-phospho-ser31-polyclonal-antibody | TH | wb western blotting blots if immunofluorescence ihc immunohistochemistry antibodies rate-limiting enzymes synthesis catecholamines dopamine norepinephrine markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's diseases drug abuse signaling phosphorylation phospho-specific regulation cells identification phospho-specific immunoblotting | ||||
| 10604 | Tyrosine Hydroxylase Polyclonal Antibody | - | 2009-10-23 | 0.225127087872 | tyrosine-hydroxylase-polyclonal-antibody | TH | gamma inhibits inhibitors neurotransmitters WB western blots blotting enzymes synthesis dopamine norepinephrine immunoblotting IHC immunohistochemistry IF immunofluorescence | ||||
| 10010245 |
U- |
137018-55-4 | ≥98% |
|
2008-07-08 | 0E-12 | u-83836e | PNU-83836E | antioxidant anti-oxidant oxidative injury stress free radicals ischemia diabetes a-tocopherol .alpha.-tocopherol 122003-11-6 | ||
| 10045 | UCM707 | 390824-20-1 | >98% |
|
2004-01-30 | 29.793149171271 | ucm707 | cannabinoids neurotransmitter inhibitors AEA lipids CB1 UR1 receptors anandamide hydrolysis fatty acids neurochemistry neuroscience | |||
| 13261 | URB447 Exclusive | 1132922-57-6 | ≥98% |
|
✓ | 2009-06-18 | 29.640718232043 | urb447 | CB1 CB2 cannabinoids antagonists obesity SR 141716A SR141716A rimonabant blood brains barrier URB appetite suppressant receptors URB-447 URB blocking peptides 447 | ||
| 10046 | URB597 | 546141-08-6 | >98% |
|
84.039314917127 | urb597 | FAAH fatty acid amide hydrolases inhibitors URB-597 anandamides lipids inhibition selective selectivity AEA inhibits hydrolysis hydrolyze arachidonoyl ethanolamides neuroscience neurochemistry | ||||
| 10007457 | URB602 | 565460-15-3 | >98% |
|
2005-09-06 | 56.447444751380 | urb602 | monoglycerol lipase MGL inhibition inhibits inhibitors rat brain enzymes enhanced stress-induced analgesia novel drugs pain stress management CNS central nervous system monoacylglycerol neuroscience neurochemistry | |||
| 10007691 | URB754 | 86672-58-4 | >98% |
|
2005-11-04 | 43.511919889502 | urb754 | neurochemistry neuroscience 2-AG 2-archidonoyl glyerol MGL monoacylglycerol lipase monoglyceride lipase endocannabinoids FAAH fatty acid amide hydrolase inhibitor inhibition inhibits monoglycerol MAGL neurochemistry | |||
| 10006731 | VDM11 | 313998-81-1 | >98% |
|
2005-07-13 | 18.877872928176 | vdm11 | analogs arachidonoyls ethanolamides AEA anadamides potentiates activity inhibits inhibition reuptake neurons FAAH fatty amides acyls hydrolases transport CB1 CB2 cannabinoids VR1 vanilloid receptors AM404 glutamergic synaptic transmission hippocampal mechanisms sodium channels neurochemistry neuroscience | |||
| 10009023 |
WIN 55212- |
131543-23-2 | >98% |
|
2006-10-05 | 49.496091617033 | win-55212-2-mesylate | WIN-2 agonists cannabinoids CB1 CB2 neurons rat glutamates SR141716A IP3 Xestospongin C 55212-3 WIN-3 inflammatory neuropeptides CGRP trigeminal neurochemistry ganglions TG exocytosis WIN55,212-2 endocrinology WIN55212-2 | |||
| 10011213 | WWL70 Exclusive | 947669-91-2 | >97% |
|
✓ | 2008-04-15 | 14.657817679557 | wwl70 | serine hydrolase ABHD6 inhibitors inhibits inhibition 2-AG endocannabinoids .alpha./.beta. a/b alpha/beta neurochemistry | ||
| 80340 |
α- |
73477-53-9 | >98% |
|
5.324972375690 | -guanidinoglutaric-acid | GGA | nitric oxide synthase inhibitors nNOS NO seizure brain neurochemistry | |||
| 78050 |
(−)- |
487-79-6 | >98% |
|
2004-04-08 | 32.607679558011 | -kainic-acid | neuroexcitatory seizures neuroexcitotoxics epileptogenics alga algae neurochemistry neuroscience | |||
| 90215 |
α- |
57086-93-8 | >98% |
|
✓ | 10.830134175217 | -linolenoyl-ethanolamide | cannabinoids neurotransmitters ethanolamides fatty acids CB alpha-linolenoyl .alpha.-linolenoyl cannabinergic neurochemistry neuroscience ethanolamines |
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA
Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640
Copyright 2010 Cayman Chemical Company
Quick Search